cluster	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
MD1	hsa04014	Ras signaling pathway	3/7	234/7846	0.000838741134630809	0.0377433510583864	0.0291352183608597	GRIN2B/PLA2G4C/KSR2	3
MD8	hsa00100	Steroid biosynthesis	4/14	20/7846	3.0240037747374e-08	1.30032162313708e-06	1.20960150989496e-06	FDFT1/DHCR24/SQLE/MSMO1	4
MD8	hsa00900	Terpenoid backbone biosynthesis	3/14	22/7846	6.82822274294195e-06	0.000146806788973252	0.000136564454858839	FDPS/HMGCR/IDI1	3
MD8	hsa01100	Metabolic pathways	8/14	1488/7846	0.00165612744587322	0.0237378267241828	0.0220816992783095	GSTM3/FDPS/FDFT1/DHCR24/SQLE/MSMO1/HMGCR/IDI1	8
MD9	hsa03030	DNA replication	4/10	36/7846	7.68779729520618e-08	1.6144374319933e-06	8.90166002602821e-07	MCM4/MCM7/MCM3/MCM2	4
MD9	hsa04110	Cell cycle	4/10	124/7846	1.15975827953817e-05	0.000121774619351508	6.7143900394315e-05	MCM4/MCM7/MCM3/MCM2	4
MD14	hsa04141	Protein processing in endoplasmic reticulum	5/10	166/7846	9.23428417568508e-07	6.37165608122271e-05	3.88811965292004e-05	DNAJB11/CALR/XBP1/HSPA5/HSP90B1	5
MD14	hsa05169	Epstein-Barr virus infection	3/10	199/7846	0.00169072396063177	0.029164988320898	0.0177970943224397	GADD45B/MYC/CALR	3
MD14	hsa04151	PI3K-Akt signaling pathway	3/10	355/7846	0.00869024660659784	0.0461251550657885	0.0281465477136772	THBS1/MYC/HSP90B1	3
MD16	hsa04141	Protein processing in endoplasmic reticulum	9/37	166/7846	5.11809277059843e-08	5.98816854160017e-06	3.98672489499246e-06	DNAJA1/HSPH1/DNAJB1/HSPA1A/HSPA1B/HSP90AB1/HSPA8/HSP90AA1/PPP1R15A	9
MD16	hsa04657	IL-17 signaling pathway	7/37	94/7846	2.17154236718716e-07	1.27035228480449e-05	8.45758606167631e-06	NFKBIA/HSP90AB1/HSP90AA1/JUND/JUN/FOSB/FOS	7
MD16	hsa04612	Antigen processing and presentation	6/37	68/7846	6.37324770558167e-07	2.48556660517685e-05	1.65480817618612e-05	HLA-E/HSPA1A/HSPA1B/HSP90AB1/HSPA8/HSP90AA1	6
MD16	hsa04380	Osteoclast differentiation	7/37	127/7846	1.69593609094107e-06	4.96061306600262e-05	3.30261238762207e-05	NFKBIA/JUND/SOCS3/JUNB/JUN/FOSB/FOS	7
MD16	hsa04915	Estrogen signaling pathway	7/37	139/7846	3.109492609495e-06	7.27621270621831e-05	4.84426217058169e-05	HSPA1A/HSPA1B/HSP90AB1/HSPA8/HSP90AA1/JUN/FOS	7
MD16	hsa05134	Legionellosis	5/37	57/7846	6.17783448519482e-06	0.000109201108964479	7.27024926978988e-05	NFKBIA/HSPA1A/HSPA1B/HSPD1/HSPA8	5
MD16	hsa04010	MAPK signaling pathway	9/37	295/7846	6.5333996816355e-06	0.000109201108964479	7.27024926978988e-05	HSPB1/NR4A1/DUSP1/HSPA1A/HSPA1B/HSPA8/JUND/JUN/FOS	9
MD16	hsa04668	TNF signaling pathway	6/37	114/7846	1.32770526044949e-05	0.000194176894340737	0.000129276564833239	IRF1/NFKBIA/SOCS3/JUNB/JUN/FOS	6
MD16	hsa03040	Spliceosome	6/37	135/7846	3.48128238988571e-05	0.000452566710685143	0.000301303972925781	DDX5/EIF4A3/HNRNPU/HSPA1A/HSPA1B/HSPA8	6
MD16	hsa05162	Measles	6/37	140/7846	4.27433243665959e-05	0.000500096895089171	0.000332948000329273	NFKBIA/HSPA1A/HSPA1B/HSPA8/JUN/FOS	6
MD16	hsa04659	Th17 cell differentiation	5/37	105/7846	0.000120966012083539	0.00128663849216127	0.000856601425280561	NFKBIA/HSP90AB1/HSP90AA1/JUN/FOS	5
MD16	hsa05418	Fluid shear stress and atherosclerosis	5/37	140/7846	0.00046360213994083	0.00436918530637815	0.0029088593132882	DUSP1/HSP90AB1/HSP90AA1/JUN/FOS	5
MD16	hsa05166	Human T-cell leukemia virus 1 infection	6/37	218/7846	0.000485465034042017	0.00436918530637815	0.0029088593132882	NFKBIA/HLA-E/JUN/EGR1/FOS/ZFP36	6
MD16	hsa04621	NOD-like receptor signaling pathway	5/37	180/7846	0.00144437933146624	0.0120708844129678	0.00803639628033846	NAMPT/NFKBIA/HSP90AB1/HSP90AA1/JUN	5
MD16	hsa05145	Toxoplasmosis	4/37	110/7846	0.00169158789865862	0.0128049092341441	0.00852508576992052	NFKBIA/HSPA1A/HSPA1B/HSPA8	4
MD16	hsa05167	Kaposi sarcoma-associated herpesvirus infection	5/37	188/7846	0.00175109869868638	0.0128049092341441	0.00852508576992052	NFKBIA/HLA-E/JUN/FOS/ZFP36	5
MD16	hsa04213	Longevity regulating pathway - multiple species	3/37	64/7846	0.0033005997064199	0.0227158920971252	0.0151234909148652	HSPA1A/HSPA1B/HSPA8	3
MD16	hsa04210	Apoptosis	4/37	138/7846	0.00385789946298962	0.0250763465094325	0.0166950035240486	NFKBIA/MCL1/JUN/FOS	4
MD16	hsa05031	Amphetamine addiction	3/37	69/7846	0.00408410461325544	0.0251494863026782	0.0167436975834295	JUN/FOSB/FOS	3
MD16	hsa04917	Prolactin signaling pathway	3/37	72/7846	0.00460410503045653	0.0266645595044696	0.0177523832958232	IRF1/SOCS3/FOS	3
MD16	hsa05140	Leishmaniasis	3/37	73/7846	0.00478594657772531	0.0266645595044696	0.0177523832958232	NFKBIA/JUN/FOS	3
MD16	hsa05133	Pertussis	3/37	76/7846	0.00535741465191083	0.0284917051942531	0.0189688365665742	IRF1/JUN/FOS	3
MD16	hsa04662	B cell receptor signaling pathway	3/37	81/7846	0.00639801841451893	0.0325464414999441	0.0216683461178216	NFKBIA/JUN/FOS	3
MD16	hsa04658	Th1 and Th2 cell differentiation	3/37	90/7846	0.00855778023414529	0.0412825917659681	0.027484586510856	NFKBIA/JUN/FOS	3
MD16	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/37	91/7846	0.00882106661665986	0.0412825917659681	0.027484586510856	NFKBIA/JUN/FOS	3
MD16	hsa05215	Prostate cancer	3/37	99/7846	0.0110993429237239	0.0488038384252679	0.0324919841967596	NFKBIA/HSP90AB1/HSP90AA1	3
MD16	hsa05142	Chagas disease (American trypanosomiasis)	3/37	103/7846	0.012354816863241	0.0488038384252679	0.0324919841967596	NFKBIA/JUN/FOS	3
MD16	hsa04620	Toll-like receptor signaling pathway	3/37	104/7846	0.0126809588974193	0.0488038384252679	0.0324919841967596	NFKBIA/JUN/FOS	3
MD16	hsa04660	T cell receptor signaling pathway	3/37	105/7846	0.013012035494061	0.0488038384252679	0.0324919841967596	NFKBIA/JUN/FOS	3
MD16	hsa04625	C-type lectin receptor signaling pathway	3/37	106/7846	0.0133480583727228	0.0488038384252679	0.0324919841967596	IRF1/NFKBIA/JUN	3
MD16	hsa04928	Parathyroid hormone synthesis, secretion and action	3/37	106/7846	0.0133480583727228	0.0488038384252679	0.0324919841967596	JUND/EGR1/FOS	3
MD25	hsa03010	Ribosome	6/23	150/7846	3.40932259984754e-06	0.00023524325938948	0.000197381834728016	RSL24D1/RPS4Y1/MRPS21/RPL35/RPL12/RPS7	6
MD25	hsa00190	Oxidative phosphorylation	4/23	132/7846	0.000528805016913697	0.0156056237367659	0.0130939634709707	COX4I1/NDUFS5/COX6C/ATP5L	4
MD25	hsa05012	Parkinson disease	4/23	141/7846	0.000678505379859389	0.0156056237367659	0.0130939634709707	COX4I1/NDUFS5/COX6C/PARK7	4
MD25	hsa05010	Alzheimer disease	4/23	170/7846	0.00136508824174734	0.0235477721701416	0.0197578561305536	COX4I1/NDUFS5/COX6C/CALM2	4
MD25	hsa04540	Gap junction	3/23	88/7846	0.0020528446312033	0.0245721855678346	0.0206173944505096	TUBA1A/TUBB/TUBA1B	3
MD25	hsa05016	Huntington disease	4/23	192/7846	0.00213671178850736	0.0245721855678346	0.0206173944505096	SOD1/COX4I1/NDUFS5/COX6C	4
MD25	hsa04714	Thermogenesis	4/23	230/7846	0.004107462872782	0.0404878483174226	0.0339714974440617	COX4I1/NDUFS5/COX6C/ATP5L	4
MD26	hsa05100	Bacterial invasion of epithelial cells	4/33	75/7846	0.000255464099311364	0.0270208462190925	0.0222874222545539	ARPC5/RHOA/ACTB/ACTG1	4
MD26	hsa04921	Oxytocin signaling pathway	5/33	153/7846	0.000403296212225261	0.0270208462190925	0.0222874222545539	RHOA/GNAS/ACTB/ACTG1/CALM1	5
MD26	hsa05110	Vibrio cholerae infection	3/33	50/7846	0.00116141295961361	0.0358265857803394	0.0295506009971378	GNAS/ACTB/ACTG1	3
MD26	hsa05135	Yersinia infection	4/33	122/7846	0.00160661614144952	0.0358265857803394	0.0295506009971378	ACTR2/RHOA/ACTB/ACTG1	4
MD26	hsa04611	Platelet activation	4/33	125/7846	0.00175706026815628	0.0358265857803394	0.0295506009971378	RHOA/GNAS/ACTB/ACTG1	4
MD26	hsa04015	Rap1 signaling pathway	5/33	212/7846	0.00175910254766173	0.0358265857803394	0.0295506009971378	RHOA/GNAS/ACTB/ACTG1/CALM1	5
MD26	hsa04810	Regulation of actin cytoskeleton	5/33	215/7846	0.00187153806315206	0.0358265857803394	0.0295506009971378	ARPC5/RHOA/TMSB4X/ACTB/ACTG1	5
MD26	hsa04714	Thermogenesis	5/33	230/7846	0.00251479694158276	0.0376897517433253	0.0310873836060421	GNAS/ACTB/ACTG1/COX7A2L/ATP5B	5
MD26	hsa05418	Fluid shear stress and atherosclerosis	4/33	140/7846	0.00265885635668966	0.0376897517433253	0.0310873836060421	RHOA/ACTB/ACTG1/CALM1	4
MD26	hsa05131	Shigellosis	5/33	236/7846	0.00281266804054666	0.0376897517433253	0.0310873836060421	ARPC5/CAPNS1/RHOA/ACTB/ACTG1	5
MD26	hsa04520	Adherens junction	3/33	71/7846	0.00318952648395093	0.038854231713584	0.0320478737621863	RHOA/ACTB/ACTG1	3
MD26	hsa04971	Gastric acid secretion	3/33	75/7846	0.00372545588850551	0.0416009240883116	0.0343134094993929	GNAS/ACTB/CALM1	3
MD26	hsa05132	Salmonella infection	3/33	78/7846	0.00416146271109749	0.042895077175928	0.0353808570579139	ARPC5/ACTB/ACTG1	3
MD26	hsa04530	Tight junction	4/33	169/7846	0.00522167350573913	0.0499788749835031	0.0412237382032037	ACTR2/RHOA/ACTB/ACTG1	4
MD27	hsa03010	Ribosome	46/57	150/7846	7.09422902494543e-72	2.27015328798254e-70	2.27015328798254e-70	RPL24/RPL27/RPL36/RPL26/RPL30/RPL13/RPL32/RPS15A/RPL7/RPS24/RPL13A/RPL19/RPL38/RPL35A/RPS5/RPS18/RPS3A/RPL6/RPLP2/RPL10A/RPL8/RPS27A/RPS4X/RPL37A/RPL15/RPL27A/RPLP0/RPS16/RPL31/RPS12/RPL23/RPL34/RPS23/RPS3/RPS17/RPL11/RPS20/RPL22/RPL9/RPL4/RPL5/RPS6/RPL3/RPLP1/RPS11/RPL14	46
MD32	hsa04974	Protein digestion and absorption	5/13	95/7846	2.79049654886311e-07	1.17200855052251e-05	9.10583084365857e-06	SLC1A5/COL5A2/COL3A1/COL1A2/COL1A1	5
MD32	hsa04933	AGE-RAGE signaling pathway in diabetic complications	4/13	102/7846	1.75945700024362e-05	0.00036948597005116	0.000287069300039748	COL3A1/COL1A2/COL1A1/MMP2	4
MD32	hsa04926	Relaxin signaling pathway	4/13	131/7846	4.7225849663466e-05	0.000661161895288524	0.000513684680549981	COL3A1/COL1A2/COL1A1/MMP2	4
MD32	hsa05205	Proteoglycans in cancer	4/13	206/7846	0.000273944302747449	0.00287641517884821	0.00223480878557129	FZD1/COL1A2/COL1A1/MMP2	4
MD32	hsa05146	Amoebiasis	3/13	102/7846	0.000555007552255485	0.00466206343894607	0.00362215455156211	COL3A1/COL1A2/COL1A1	3
MD32	hsa04611	Platelet activation	3/13	125/7846	0.00100465965944159	0.00703261761609116	0.00546393849871744	COL3A1/COL1A2/COL1A1	3
MD32	hsa04550	Signaling pathways regulating pluripotency of stem cells	3/13	141/7846	0.00142385128787127	0.0085431077272276	0.00663750224421192	IL6ST/FZD1/LIFR	3
MD33	hsa04726	Serotonergic synapse	3/6	113/7846	5.63769382206116e-05	0.00412210556811348	0.00240033023003248	GNAI1/PRKCB/MAOA	3
MD33	hsa04728	Dopaminergic synapse	3/6	131/7846	8.77043737896485e-05	0.00412210556811348	0.00240033023003248	GNAI1/PRKCB/MAOA	3
MD33	hsa04015	Rap1 signaling pathway	3/6	212/7846	0.000366285000455503	0.0114769300142724	0.00668309474515303	GNAI1/ANGPT1/PRKCB	3
MD36	hsa00190	Oxidative phosphorylation	12/29	132/7846	1.26179443971981e-14	9.84199662981453e-13	8.63333037703029e-13	MT-ND6/MT-ATP8/MT-CO2/MT-ND3/MT-CO3/MT-CO1/MT-ND1/MT-ND2/MT-ND5/MT-ND4/MT-ATP6/MT-CYB	12
MD36	hsa05012	Parkinson disease	12/29	141/7846	2.82801278940523e-14	1.10292498786804e-12	9.67478059533369e-13	MT-ND6/MT-ATP8/MT-CO2/MT-ND3/MT-CO3/MT-CO1/MT-ND1/MT-ND2/MT-ND5/MT-ND4/MT-ATP6/MT-CYB	12
MD36	hsa04714	Thermogenesis	12/29	230/7846	1.01141415294818e-11	2.62967679766526e-10	2.3067340330397e-10	MT-ND6/MT-ATP8/MT-CO2/MT-ND3/MT-CO3/MT-CO1/MT-ND1/MT-ND2/MT-ND5/MT-ND4/MT-ATP6/MT-CYB	12
MD36	hsa04723	Retrograde endocannabinoid signaling	6/29	147/7846	1.29981103617521e-05	0.000253463152054165	0.000222336098293127	MT-ND6/MT-ND3/MT-ND1/MT-ND2/MT-ND5/MT-ND4	6
MD36	hsa05010	Alzheimer disease	6/29	170/7846	2.97469817722275e-05	0.000464052915646749	0.00040706396109364	MT-ATP8/MT-CO2/MT-CO3/MT-CO1/MT-ATP6/MT-CYB	6
MD36	hsa05016	Huntington disease	6/29	192/7846	5.89857620463812e-05	0.000766814906602955	0.000672644654914873	MT-ATP8/MT-CO2/MT-CO3/MT-CO1/MT-ATP6/MT-CYB	6
MD36	hsa01100	Metabolic pathways	15/29	1488/7846	7.26548675133859e-05	0.000809582809434871	0.000710160359153396	SUCLG1/GANAB/GLS/MT-ND6/MT-ATP8/MT-CO2/MT-ND3/MT-CO3/MT-CO1/MT-ND1/MT-ND2/MT-ND5/MT-ND4/MT-ATP6/MT-CYB	15
MD36	hsa04260	Cardiac muscle contraction	4/29	85/7846	0.000247850659106648	0.00241654392628981	0.00211977537393843	MT-CO2/MT-CO3/MT-CO1/MT-CYB	4
MD36	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	4/29	150/7846	0.00210096167648785	0.0182083345295614	0.015972223271545	MT-CO2/MT-CO3/MT-CO1/MT-CYB	4
MD39	hsa05010	Alzheimer disease	3/13	170/7846	0.00243574429889866	0.0497712909459724	0.0202078925645302	CALM3/UQCRQ/CALM2	3
MD39	hsa04810	Regulation of actin cytoskeleton	3/13	215/7846	0.00473581579351181	0.0497712909459724	0.0202078925645302	TMSB4X/MYL12B/MYL12A	3
MD40	hsa04540	Gap junction	5/12	88/7846	1.17845203650571e-07	2.59259448031256e-06	1.9847613246412e-06	TUBB2A/TUBB/TUBB4B/TUBA1B/TUBA1A	5
MD40	hsa04145	Phagosome	5/12	148/7846	1.5892403100215e-06	1.74816434102365e-05	1.33830762949179e-05	TUBB2A/TUBB/TUBB4B/TUBA1B/TUBA1A	5
MD40	hsa05130	Pathogenic Escherichia coli infection	5/12	200/7846	7.01033888617076e-06	5.14091518319189e-05	3.93562884837657e-05	TUBB2A/TUBB/TUBB4B/TUBA1B/TUBA1A	5
MD40	hsa04530	Tight junction	3/12	169/7846	0.00187180538557827	0.0102949296206805	0.00788128583401376	TUBA1B/TUBA1A/MYL6	3
MD42	hsa05416	Viral myocarditis	4/12	57/7846	1.18668492637431e-06	6.17076161714644e-05	3.87234028606355e-05	FYN/HLA-C/HLA-A/HLA-B	4
MD42	hsa04612	Antigen processing and presentation	4/12	68/7846	2.42460156592112e-06	6.30396407139491e-05	3.95592887071341e-05	CTSL/HLA-C/HLA-A/HLA-B	4
MD42	hsa05330	Allograft rejection	3/12	35/7846	1.74072706899871e-05	0.000244446211459801	0.000153397420146839	HLA-C/HLA-A/HLA-B	3
MD42	hsa05332	Graft-versus-host disease	3/12	37/7846	2.06297093882925e-05	0.000244446211459801	0.000153397420146839	HLA-C/HLA-A/HLA-B	3
MD42	hsa04650	Natural killer cell mediated cytotoxicity	4/12	125/7846	2.75328217145353e-05	0.000244446211459801	0.000153397420146839	FYN/HLA-C/HLA-A/HLA-B	4
MD42	hsa04940	Type I diabetes mellitus	3/12	41/7846	2.82053320915155e-05	0.000244446211459801	0.000153397420146839	HLA-C/HLA-A/HLA-B	3
MD42	hsa05320	Autoimmune thyroid disease	3/12	50/7846	5.14586571112562e-05	0.000347723737099452	0.000218207203442976	HLA-C/HLA-A/HLA-B	3
MD42	hsa04145	Phagosome	4/12	148/7846	5.34959595537618e-05	0.000347723737099452	0.000218207203442976	CTSL/HLA-C/HLA-A/HLA-B	4
MD42	hsa04218	Cellular senescence	4/12	160/7846	7.25761753107981e-05	0.000419329012906834	0.000263141688261373	ZFP36L2/HLA-C/HLA-A/HLA-B	4
MD42	hsa04142	Lysosome	3/12	123/7846	0.000745942389271255	0.00387890042421052	0.00243412779656936	SORT1/CTSL/LAPTM4A	3
MD42	hsa04514	Cell adhesion molecules (CAMs)	3/12	144/7846	0.00117962792640925	0.00557642292484372	0.00349937470992217	HLA-C/HLA-A/HLA-B	3
MD42	hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/12	188/7846	0.00253923343307697	0.0110033448766669	0.00690493301977071	HLA-C/HLA-A/HLA-B	3
MD42	hsa05169	Epstein-Barr virus infection	3/12	199/7846	0.00298557569961436	0.0115708457917503	0.00726105707579471	HLA-C/HLA-A/HLA-B	3
MD42	hsa05203	Viral carcinogenesis	3/12	202/7846	0.00311522771316354	0.0115708457917503	0.00726105707579471	HLA-C/HLA-A/HLA-B	3
MD42	hsa05170	Human immunodeficiency virus 1 infection	3/12	212/7846	0.00357254963492768	0.012384838734416	0.00777186236370232	HLA-C/HLA-A/HLA-B	3
MD42	hsa05166	Human T-cell leukemia virus 1 infection	3/12	218/7846	0.00386586679912736	0.0125640670971639	0.00788433360348344	HLA-C/HLA-A/HLA-B	3
MD42	hsa05163	Human cytomegalovirus infection	3/12	224/7846	0.00417367347765522	0.0127665306375336	0.00801138562274377	HLA-C/HLA-A/HLA-B	3
MD42	hsa04144	Endocytosis	3/12	247/7846	0.00549194259155647	0.0158656119311631	0.00995615323615501	HLA-C/HLA-A/HLA-B	3
MD42	hsa05165	Human papillomavirus infection	3/12	332/7846	0.012423529579937	0.0340012388503539	0.021336809804878	HLA-C/HLA-A/HLA-B	3
MD45	hsa04512	ECM-receptor interaction	6/57	88/7846	3.84539764590921e-05	0.00569118851594563	0.00526212309440207	SDC4/COL4A1/COL4A4/LAMA1/ITGA6/NPNT	6
MD45	hsa04974	Protein digestion and absorption	5/57	95/7846	0.000596113997373954	0.0441124358056726	0.0407867471887442	COL4A1/COL4A4/KCNE3/SLC1A5/COL3A1	5
MD49	hsa04114	Oocyte meiosis	4/12	125/7846	2.75328217145353e-05	0.000550656434290706	0.000463710681507963	BUB1/SPDYA/STAG3/SMC1B	4
MD51	hsa05161	Hepatitis B	8/39	164/7846	1.08884519337032e-06	5.21266259776433e-05	3.35084779285774e-05	EGR2/DDX3X/CYCS/NFKBIA/ATF4/JUN/FOS/EGR3	8
MD51	hsa04010	MAPK signaling pathway	10/39	295/7846	1.16996543852051e-06	5.21266259776433e-05	3.35084779285774e-05	JUND/DUSP5/NR4A1/HSPA1A/HSPA1B/ATF4/DUSP1/GADD45B/JUN/FOS	10
MD51	hsa04141	Protein processing in endoplasmic reticulum	8/39	166/7846	1.19373952620557e-06	5.21266259776433e-05	3.35084779285774e-05	HSPA1A/HSPA1B/HSPA5/XBP1/HERPUD1/ATF4/DNAJB1/PPP1R15A	8
MD51	hsa04210	Apoptosis	7/39	138/7846	4.29843804791065e-06	0.000140773846069074	9.04934325875927e-05	CYCS/NFKBIA/ATF4/GADD45B/JUN/MCL1/FOS	7
MD51	hsa04380	Osteoclast differentiation	6/39	127/7846	3.36483831234063e-05	0.000881587637833244	0.000566709610499474	JUND/JUNB/NFKBIA/JUN/FOS/FOSB	6
MD51	hsa05162	Measles	6/39	140/7846	5.82533192008404e-05	0.00127186413588502	0.000817590444924076	HSPA1A/HSPA1B/CYCS/NFKBIA/JUN/FOS	6
MD51	hsa05166	Human T-cell leukemia virus 1 infection	7/39	218/7846	8.37169714808414e-05	0.00151523020581882	0.000974033077264007	EGR2/NFKBIA/ATF4/JUN/FOS/EGR1/ZFP36	7
MD51	hsa04657	IL-17 signaling pathway	5/39	94/7846	9.25331423400806e-05	0.00151523020581882	0.000974033077264007	JUND/NFKBIA/JUN/FOS/FOSB	5
MD51	hsa05134	Legionellosis	4/39	57/7846	0.000170398783687304	0.00248024896255965	0.00159437458420869	HSPA1A/HSPA1B/CYCS/NFKBIA	4
MD51	hsa04668	TNF signaling pathway	5/39	114/7846	0.000230191134211548	0.00301550385817127	0.0019384516565183	JUNB/NFKBIA/ATF4/JUN/FOS	5
MD51	hsa05031	Amphetamine addiction	4/39	69/7846	0.00035730196802847	0.00425514161924814	0.00273532607103135	ATF4/JUN/FOS/FOSB	4
MD51	hsa05203	Viral carcinogenesis	6/39	202/7846	0.000433977593987875	0.00473758873436763	0.00304545679991491	EGR2/DDX3X/NFKBIA/ATF4/JUN/EGR3	6
MD51	hsa03040	Spliceosome	5/39	135/7846	0.000503844596153748	0.0050772032381647	0.00326377066334412	DDX5/HSPA1A/HSPA1B/SRSF7/EIF4A3	5
MD51	hsa04915	Estrogen signaling pathway	5/39	139/7846	0.000575918880577196	0.00538895523968662	0.00346417371775757	HSPA1A/HSPA1B/ATF4/JUN/FOS	5
MD51	hsa05020	Prion diseases	3/39	35/7846	0.000665814222319595	0.00581477754159113	0.00373790440600474	HSPA1A/HSPA5/EGR1	3
MD51	hsa05210	Colorectal cancer	4/39	88/7846	0.000900681851565386	0.0073743326596916	0.00474043079771256	CYCS/GADD45B/JUN/FOS	4
MD51	hsa05030	Cocaine addiction	3/39	49/7846	0.00178635630164065	0.0124081432818968	0.00797630745320805	ATF4/JUN/FOSB	3
MD51	hsa04625	C-type lectin receptor signaling pathway	4/39	106/7846	0.00179965436913007	0.0124081432818968	0.00797630745320805	EGR2/NFKBIA/JUN/EGR3	4
MD51	hsa04928	Parathyroid hormone synthesis, secretion and action	4/39	106/7846	0.00179965436913007	0.0124081432818968	0.00797630745320805	JUND/ATF4/FOS/EGR1	4
MD51	hsa05202	Transcriptional misregulation in cancer	5/39	184/7846	0.00202515449410412	0.0128624022602565	0.0082683180459664	ID2/NFKBIZ/DDX5/H3F3B/GADD45B	5
MD51	hsa05145	Toxoplasmosis	4/39	110/7846	0.00206191181271287	0.0128624022602565	0.0082683180459664	HSPA1A/HSPA1B/CYCS/NFKBIA	4
MD51	hsa05167	Kaposi sarcoma-associated herpesvirus infection	5/39	188/7846	0.00222528621012895	0.013250567887586	0.00851784195264669	CYCS/NFKBIA/JUN/FOS/ZFP36	5
MD51	hsa04926	Relaxin signaling pathway	4/39	131/7846	0.00388363670089175	0.0221198438181226	0.014219264808757	NFKBIA/ATF4/JUN/FOS	4
MD51	hsa04612	Antigen processing and presentation	3/39	68/7846	0.00455321382978555	0.0248529588209128	0.0159761888764405	HSPA1A/HSPA1B/HSPA5	3
MD51	hsa05140	Leishmaniasis	3/39	73/7846	0.00555501075831982	0.0291082563735959	0.0187116151859194	NFKBIA/JUN/FOS	3
MD51	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	4/39	150/7846	0.00627752602583027	0.0316290734378371	0.0203320680998551	XBP1/CYCS/ATF4/JUN	4
MD51	hsa04662	B cell receptor signaling pathway	3/39	81/7846	0.00741505069947489	0.0359767274678226	0.0231268637800386	NFKBIA/JUN/FOS	3
MD51	hsa04658	Th1 and Th2 cell differentiation	3/39	90/7846	0.0099015428263098	0.0460951830436667	0.0296312948452659	NFKBIA/JUN/FOS	3
MD51	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/39	91/7846	0.0102042771623384	0.0460951830436667	0.0296312948452659	NFKBIA/JUN/FOS	3
MD51	hsa04912	GnRH signaling pathway	3/39	93/7846	0.0108258624750174	0.0470955544159475	0.0302743620190904	ATF4/JUN/EGR1	3
MD51	hsa05222	Small cell lung cancer	3/39	94/7846	0.0111447495182777	0.0470955544159475	0.0302743620190904	CYCS/NFKBIA/GADD45B	3
MD53	hsa04145	Phagosome	4/11	148/7846	3.61937198058482e-05	0.000988582825130706	0.000448892098098566	RAB5B/SEC61G/ACTB/ACTG1	4
MD53	hsa05110	Vibrio cholerae infection	3/11	50/7846	3.87679539266943e-05	0.000988582825130706	0.000448892098098566	SEC61G/ACTB/ACTG1	3
MD53	hsa04714	Thermogenesis	3/11	230/7846	0.00344611694608831	0.0322798274245265	0.0146575067768748	ATP5G3/ACTB/ACTG1	3
MD54	hsa00190	Oxidative phosphorylation	3/5	132/7846	4.54184486777638e-05	0.000545021384133165	0.000143426680035043	NDUFS5/ATP5I/NDUFA1	3
MD54	hsa04714	Thermogenesis	3/5	230/7846	0.000238051144232787	0.00142830686539672	0.00037587022773598	NDUFS5/ATP5I/NDUFA1	3
MD55	hsa03010	Ribosome	5/16	150/7846	8.80521357724695e-06	0.000387429397398866	0.000315133959606733	RPL23A/RPS29/UBA52/RPL18/RPS25	5
MD55	hsa00190	Oxidative phosphorylation	4/16	132/7846	0.000119085801079096	0.00261988762374012	0.00213100907194172	ATP5B/UQCRHL/UQCRH/ATP5L	4
MD55	hsa04714	Thermogenesis	4/16	230/7846	0.000991699102068831	0.0145449201636762	0.0118307963053825	ATP5B/UQCRHL/UQCRH/ATP5L	4
MD55	hsa05012	Parkinson disease	3/16	141/7846	0.00267998925057901	0.0294798817563692	0.0239788511893912	ATP5B/UQCRHL/UQCRH	3
MD55	hsa05010	Alzheimer disease	3/16	170/7846	0.00454686797845576	0.0400124382104107	0.0325460023721044	ATP5B/UQCRHL/UQCRH	3
MD55	hsa05016	Huntington disease	3/16	192/7846	0.00638614912108145	0.046831760221264	0.0380928193187315	ATP5B/UQCRHL/UQCRH	3
MD56	hsa03010	Ribosome	61/74	150/7846	1.05454309148773e-97	4.32362667509971e-96	4.32362667509971e-96	RPL15/RPS10/RPS28/RPL41/RPL37/RPL10/RPL39/RPL24/RPS19/RPL29/RPS5/RPS2/RPS16/RPL35A/RPL32/RPLP1/RPLP2/RPL38/RPL30/RPS7/RPS15A/RPS21/RPL21/RPL27/RPS11/RPL6/RPL12/RPL7A/RPL26/RPL14/RPL36/RPL7/RPS27A/RPL19/RPLP0/RPS24/RPL13/RPL22/RPL4/RPL27A/RPL31/RPS4X/RPS20/RPL13A/RPL8/RPS23/RPL23/RPS3A/RPS18/RPL34/RPS12/RPL11/RPS6/RPL10A/RPS17/RPL5/RPS3/RPL3/RPL37A/RPL9/RPL35	61
MD59	hsa04974	Protein digestion and absorption	7/44	95/7846	8.11654391040013e-07	7.95421303219212e-05	6.92042164992011e-05	ELN/COL14A1/COL5A1/COL5A2/COL3A1/COL1A2/COL1A1	7
MD59	hsa04350	TGF-beta signaling pathway	6/44	94/7846	1.23168658010386e-05	0.000603526424250893	0.000525087436781121	BMP7/LTBP1/FBN1/THSD4/ACVR2A/NEO1	6
MD59	hsa04360	Axon guidance	7/44	183/7846	6.18345859563026e-05	0.00201992980790589	0.00175740402191597	BMP7/BOC/WNT5A/PLXNA4/NTNG1/NRP1/NEO1	7
MD59	hsa04512	ECM-receptor interaction	5/44	88/7846	0.00012181731456057	0.00298452420673395	0.00259663223142267	DAG1/THBS3/COL1A2/COL1A1/THBS2	5
MD59	hsa04510	Focal adhesion	6/44	201/7846	0.000822173793823688	0.0152686448594061	0.0132842130355735	FLNC/THBS3/FLNB/COL1A2/COL1A1/THBS2	6
MD59	hsa05205	Proteoglycans in cancer	6/44	206/7846	0.00093481499139221	0.0152686448594061	0.0132842130355735	FLNC/WNT5A/FLNB/COL1A2/COL1A1/GPC3	6
MD59	hsa04933	AGE-RAGE signaling pathway in diabetic complications	4/44	102/7846	0.00245254568532737	0.0343356395945831	0.0298731128588747	F3/COL3A1/COL1A2/COL1A1	4
MD60	hsa04014	Ras signaling pathway	4/10	234/7846	0.000140573180041118	0.00493428931029865	0.00334723719295113	FGFR1/NGFR/NTRK2/PDGFRA	4
MD60	hsa05215	Prostate cancer	3/10	99/7846	0.000219301747124384	0.00493428931029865	0.00334723719295113	FGFR1/PLAT/PDGFRA	3
MD60	hsa04010	MAPK signaling pathway	4/10	295/7846	0.000343626340354778	0.00515439510532166	0.00349654872641703	FGFR1/NGFR/NTRK2/PDGFRA	4
MD60	hsa04151	PI3K-Akt signaling pathway	4/10	355/7846	0.000696375680373661	0.00783422640420369	0.00531444598179899	FGFR1/NGFR/NTRK2/PDGFRA	4
MD60	hsa04015	Rap1 signaling pathway	3/10	212/7846	0.00202815979374836	0.0182534381437353	0.0123824492670953	FGFR1/NGFR/PDGFRA	3
MD62	hsa00100	Steroid biosynthesis	5/18	20/7846	5.25781692172834e-10	1.647585898059e-08	1.078078966013e-08	NSDHL/FDFT1/MSMO1/SQLE/DHCR24	5
MD62	hsa00900	Terpenoid backbone biosynthesis	5/18	22/7846	8.90586971923784e-10	1.647585898059e-08	1.078078966013e-08	FDPS/ACAT2/HMGCS1/IDI1/HMGCR	5
MD62	hsa01100	Metabolic pathways	13/18	1488/7846	1.29225168670856e-06	1.59377708027389e-05	1.04286978225603e-05	NSDHL/FADS1/FDPS/ACSL3/ACAT2/HMGCS1/IDI1/HMGCR/FDFT1/MSMO1/SQLE/DHCR24/SCD	13
MD62	hsa01212	Fatty acid metabolism	4/18	56/7846	6.61250452622056e-06	6.11656668675402e-05	4.0023053711335e-05	FADS1/ACSL3/ACAT2/SCD	4
MD62	hsa03320	PPAR signaling pathway	3/18	76/7846	0.000641950964412337	0.00395869761387608	0.00259032845289189	ACSL3/HMGCS1/SCD	3
MD65	hsa04141	Protein processing in endoplasmic reticulum	5/16	166/7846	1.44360010373369e-05	0.000765108054978856	0.000638223203755948	DDIT3/DNAJB11/XBP1/HSPA5/HSP90B1	5
MD66	hsa04141	Protein processing in endoplasmic reticulum	13/83	166/7846	1.55780291007275e-08	2.66384297622441e-06	1.91855726819487e-06	ERO1B/SKP1/HERPUD1/ATF4/PPP1R15A/HSP90AB1/HSPA1A/HSPA1B/HSPA8/DNAJB1/HSPH1/HSP90AA1/DNAJA1	13
MD66	hsa04210	Apoptosis	9/83	138/7846	1.3530838841779e-05	0.000817626880592197	0.000588872545578868	TUBA1B/TUBA1A/TUBA1C/NFKBIA/GADD45B/ATF4/JUN/FOS/MCL1	9
MD66	hsa04915	Estrogen signaling pathway	9/83	139/7846	1.43443312384596e-05	0.000817626880592197	0.000588872545578868	CALM1/ATF4/HSP90AB1/HSPA1A/HSPA1B/HSPA8/HSP90AA1/JUN/FOS	9
MD66	hsa05161	Hepatitis B	9/83	164/7846	5.34634603927265e-05	0.0019141663832824	0.00137862398795962	NFKBIA/EGR2/DDX3X/MYC/CDKN1A/EGR3/ATF4/JUN/FOS	9
MD66	hsa04657	IL-17 signaling pathway	7/83	94/7846	5.59697772889591e-05	0.0019141663832824	0.00137862398795962	NFKBIA/JUND/HSP90AB1/HSP90AA1/JUN/FOS/FOSB	7
MD66	hsa05031	Amphetamine addiction	6/83	69/7846	8.22405245631428e-05	0.00203237875386867	0.00146376309142896	SIRT1/CALM1/ATF4/JUN/FOS/FOSB	6
MD66	hsa03040	Spliceosome	8/83	135/7846	8.31967910940393e-05	0.00203237875386867	0.00146376309142896	TRA2B/SRSF7/SRSF3/SRSF5/DDX5/HSPA1A/HSPA1B/HSPA8	8
MD66	hsa05202	Transcriptional misregulation in cancer	9/83	184/7846	0.00013007846899805	0.00278042727483333	0.00200252379904893	FUS/MLF1/ID2/MYC/CDKN1A/GADD45B/H3F3B/DDX5/NFKBIZ	9
MD66	hsa04668	TNF signaling pathway	7/83	114/7846	0.000189855507031867	0.00360725463360548	0.0025980227278045	NFKBIA/ATF4/IRF1/JUNB/SOCS3/JUN/FOS	7
MD66	hsa04010	MAPK signaling pathway	11/83	295/7846	0.000254217724734968	0.00434712309296796	0.00313089197831487	MYC/JUND/GADD45B/ATF4/DUSP5/DUSP1/HSPA1A/HSPA1B/HSPA8/JUN/FOS	11
MD66	hsa05134	Legionellosis	5/83	57/7846	0.000319150799670573	0.00496134424942436	0.00357326732645522	NFKBIA/HSPD1/HSPA1A/HSPA1B/HSPA8	5
MD66	hsa04380	Osteoclast differentiation	7/83	127/7846	0.000369250773860938	0.00526182352751836	0.00378967899488857	NFKBIA/JUND/JUNB/SOCS3/JUN/FOS/FOSB	7
MD66	hsa05166	Human T-cell leukemia virus 1 infection	9/83	218/7846	0.000461567421611196	0.00607138685350111	0.00437274399421133	NFKBIA/EGR2/MYC/CDKN1A/ATF4/ZFP36/JUN/EGR1/FOS	9
MD66	hsa05418	Fluid shear stress and atherosclerosis	7/83	140/7846	0.000664707061336298	0.00811892196346478	0.00584742302077796	KLF2/CALM1/HSP90AB1/DUSP1/HSP90AA1/JUN/FOS	7
MD66	hsa04612	Antigen processing and presentation	5/83	68/7846	0.00072557717485877	0.00814842720363388	0.00586867333225709	HSP90AB1/HSPA1A/HSPA1B/HSPA8/HSP90AA1	5
MD66	hsa05167	Kaposi sarcoma-associated herpesvirus infection	8/83	188/7846	0.000795386163500271	0.00814842720363388	0.00586867333225709	NFKBIA/UBB/MYC/CDKN1A/CALM1/ZFP36/JUN/FOS	8
MD66	hsa04625	C-type lectin receptor signaling pathway	6/83	106/7846	0.000857729179329882	0.00814842720363388	0.00586867333225709	NFKBIA/EGR2/CALM1/EGR3/IRF1/JUN	6
MD66	hsa04928	Parathyroid hormone synthesis, secretion and action	6/83	106/7846	0.000857729179329882	0.00814842720363388	0.00586867333225709	MAFB/CDKN1A/JUND/ATF4/EGR1/FOS	6
MD66	hsa05130	Pathogenic Escherichia coli infection	8/83	200/7846	0.00118884536088577	0.0106996082479719	0.00770608904286066	TUBB2A/TUBA1B/TUBA1A/TUBA1C/NFKBIA/TUBB4B/JUN/FOS	8
MD66	hsa05203	Viral carcinogenesis	8/83	202/7846	0.00126739888279502	0.0108362604478974	0.00780450890984302	NFKBIA/EGR2/DDX3X/GTF2B/CDKN1A/EGR3/ATF4/JUN	8
MD66	hsa04540	Gap junction	5/83	88/7846	0.00231281767989274	0.0179769010573482	0.012947352562079	TUBB2A/TUBA1B/TUBA1A/TUBA1C/TUBB4B	5
MD66	hsa05210	Colorectal cancer	5/83	88/7846	0.00231281767989274	0.0179769010573482	0.012947352562079	MYC/CDKN1A/GADD45B/JUN/FOS	5
MD66	hsa05222	Small cell lung cancer	5/83	94/7846	0.00308473736466098	0.0229343517111751	0.0165178156368574	CKS2/NFKBIA/MYC/CDKN1A/GADD45B	5
MD66	hsa05162	Measles	6/83	140/7846	0.00354921255649705	0.0252881394650415	0.0182130644346559	NFKBIA/HSPA1A/HSPA1B/HSPA8/JUN/FOS	6
MD66	hsa05215	Prostate cancer	5/83	99/7846	0.0038578206588178	0.0263874933063137	0.0190048428244919	NFKBIA/CDKN1A/ATF4/HSP90AB1/HSP90AA1	5
MD66	hsa04213	Longevity regulating pathway - multiple species	4/83	64/7846	0.00457011631933424	0.029522282974288	0.0212625860756645	SIRT1/HSPA1A/HSPA1B/HSPA8	4
MD66	hsa04145	Phagosome	6/83	148/7846	0.00466141310120337	0.029522282974288	0.0212625860756645	TUBB2A/TUBA1B/TUBA1A/TUBA1C/TFRC/TUBB4B	6
MD66	hsa04659	Th17 cell differentiation	5/83	105/7846	0.00495828662040231	0.0302809647174569	0.0218090050596643	NFKBIA/HSP90AB1/HSP90AA1/JUN/FOS	5
MD66	hsa05216	Thyroid cancer	3/83	37/7846	0.00684572691187492	0.0403661828251935	0.0290725970486158	MYC/CDKN1A/GADD45B	3
MD66	hsa05133	Pertussis	4/83	76/7846	0.00838799485797643	0.0478115706904657	0.0344349262590611	CALM1/IRF1/JUN/FOS	4
MD66	hsa05220	Chronic myeloid leukemia	4/83	78/7846	0.00917896288545366	0.0497044763417001	0.0357982378084266	NFKBIA/MYC/CDKN1A/GADD45B	4
MD66	hsa05200	Pathways in cancer	12/83	531/7846	0.00955745261335719	0.0497044763417001	0.0357982378084266	SKP1/EGLN3/CKS2/NFKBIA/MYC/CDKN1A/CALM1/GADD45B/HSP90AB1/HSP90AA1/JUN/FOS	12
MD66	hsa03018	RNA degradation	4/83	79/7846	0.00959209192559124	0.0497044763417001	0.0357982378084266	TOB1/BTG1/HSPD1/BTG2	4
MD67	hsa04714	Thermogenesis	3/7	230/7846	0.000797522019078729	0.0127603523052597	0.00839496862188135	COA3/COX4I1/NDUFB1	3
MD68	hsa04260	Cardiac muscle contraction	3/12	85/7846	0.000251595564057427	0.0145925427153308	0.0119176846132466	TPM3/COX6C/COX7A2	3
MD68	hsa05012	Parkinson disease	3/12	141/7846	0.00110981006338083	0.0296798164736841	0.0242394145429362	PARK7/COX6C/COX7A2	3
MD68	hsa05010	Alzheimer disease	3/12	170/7846	0.00190377905226389	0.0296798164736841	0.0242394145429362	COX6C/CALM2/COX7A2	3
MD69	hsa03010	Ribosome	5/9	150/7846	2.83091491039602e-07	4.24637236559403e-06	3.87388356159456e-06	RPS9/RPS29/RPS19/RPL23A/RPS2	5
MD70	hsa03010	Ribosome	5/17	150/7846	1.22825543357653e-05	0.00111771244455464	0.000853314301221588	RPS21/RPS28/RPL10/RPL29/RPS10	5
MD70	hsa05110	Vibrio cholerae infection	3/17	50/7846	0.000155519485941719	0.0070761366103482	0.00540225582744917	GNAS/ACTB/ACTG1	3
MD70	hsa05414	Dilated cardiomyopathy (DCM)	3/17	95/7846	0.00103397702358392	0.0288302566712038	0.0220103752492707	GNAS/ACTB/ACTG1	3
MD70	hsa04714	Thermogenesis	4/17	230/7846	0.00126726402950346	0.0288302566712038	0.0220103752492707	GNAS/ACTB/ACTG1/UQCRB	4
MD70	hsa04611	Platelet activation	3/17	125/7846	0.00228003044301039	0.0414965540627891	0.031680422997618	GNAS/ACTB/ACTG1	3
MD70	hsa05418	Fluid shear stress and atherosclerosis	3/17	140/7846	0.00314766254154045	0.0477395485466968	0.0364466189020473	ACTB/ACTG1/SUMO2	3
MD71	hsa03010	Ribosome	53/58	150/7846	1.17005259235516e-89	2.10609466623929e-88	2.09377832316187e-88	RPL35/RPL39/RPL37/RPL36/FAU/RPS7/RPS5/RPL7A/RPL35A/RPL7/RPL26/RPL19/RPS15A/RPL24/RPL14/RPL30/RPL15/RPS25/RPLP1/RPL27/RPL38/RPL32/RPL13/RPS18/RPLP2/RPL8/RPS11/RPL10A/RPL13A/RPS16/RPS27A/RPL22/RPL3/RPL6/RPS24/RPS4X/RPL4/RPLP0/RPL31/RPL11/RPS20/RPS3/RPS17/RPS12/RPL5/RPL9/RPS6/RPL37A/RPS3A/RPL27A/RPS23/RPL34/RPL23	53
MD72	hsa00190	Oxidative phosphorylation	11/17	132/7846	2.27876728079631e-16	9.5708225793445e-15	7.43597744259848e-15	MT-ATP8/MT-ND3/MT-ND1/MT-CO2/MT-CO1/MT-CO3/MT-ND5/MT-ND2/MT-CYB/MT-ATP6/MT-ND4	11
MD72	hsa05012	Parkinson disease	11/17	141/7846	4.81052779592626e-16	1.01021083714451e-14	7.84875587756389e-15	MT-ATP8/MT-ND3/MT-ND1/MT-CO2/MT-CO1/MT-CO3/MT-ND5/MT-ND2/MT-CYB/MT-ATP6/MT-ND4	11
MD72	hsa04714	Thermogenesis	11/17	230/7846	1.14922821031711e-13	1.60891949444396e-12	1.25003770245019e-12	MT-ATP8/MT-ND3/MT-ND1/MT-CO2/MT-CO1/MT-CO3/MT-ND5/MT-ND2/MT-CYB/MT-ATP6/MT-ND4	11
MD72	hsa05010	Alzheimer disease	7/17	170/7846	3.21084233506296e-08	3.37138445181611e-07	2.61937137860399e-07	TNFRSF1A/MT-ATP8/MT-CO2/MT-CO1/MT-CO3/MT-CYB/MT-ATP6	7
MD72	hsa05016	Huntington disease	6/17	192/7846	1.96374310562544e-06	1.64954420872537e-05	1.28160076367134e-05	MT-ATP8/MT-CO2/MT-CO1/MT-CO3/MT-CYB/MT-ATP6	6
MD72	hsa04723	Retrograde endocannabinoid signaling	5/17	147/7846	1.11300184701229e-05	7.36953260145917e-05	5.72570202118382e-05	MT-ND3/MT-ND1/MT-ND5/MT-ND2/MT-ND4	5
MD72	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	5/17	150/7846	1.22825543357653e-05	7.36953260145917e-05	5.72570202118382e-05	TNFRSF1A/MT-CO2/MT-CO1/MT-CO3/MT-CYB	5
MD72	hsa04260	Cardiac muscle contraction	4/17	85/7846	2.74238556683903e-05	0.000143975242259049	0.000111860463910539	MT-CO2/MT-CO1/MT-CO3/MT-CYB	4
MD72	hsa01100	Metabolic pathways	11/17	1488/7846	4.41155586627925e-05	0.000205872607093032	0.00015995114836802	MT-ATP8/MT-ND3/MT-ND1/MT-CO2/MT-CO1/MT-CO3/MT-ND5/MT-ND2/MT-CYB/MT-ATP6/MT-ND4	11
MD73	hsa04512	ECM-receptor interaction	5/15	88/7846	4.35122748320688e-07	2.13210146677137e-05	1.3282694422421e-05	ITGB5/COL4A2/COL6A3/COL4A1/ITGA1	5
MD73	hsa04510	Focal adhesion	6/15	201/7846	1.08317628239352e-06	2.65378189186412e-05	1.65326906260064e-05	ITGB5/PDGFRB/COL4A2/COL6A3/COL4A1/ITGA1	6
MD73	hsa05165	Human papillomavirus infection	6/15	332/7846	1.98599332501535e-05	0.000324378909752506	0.000202083531317351	ITGB5/PDGFRB/COL4A2/COL6A3/COL4A1/ITGA1	6
MD73	hsa04151	PI3K-Akt signaling pathway	6/15	355/7846	2.90846616705722e-05	0.000356287105464509	0.000221961891696472	ITGB5/PDGFRB/COL4A2/COL6A3/COL4A1/ITGA1	6
MD73	hsa04974	Protein digestion and absorption	3/15	95/7846	0.000704110316603428	0.00690028110271359	0.00429877877505251	COL4A2/COL6A3/COL4A1	3
MD73	hsa04022	cGMP-PKG signaling pathway	3/15	166/7846	0.00350941813435597	0.0286602480972405	0.017854934367776	EDNRA/TRPC6/GUCY1B3	3
MD73	hsa04810	Regulation of actin cytoskeleton	3/15	215/7846	0.00723598890868661	0.0443204320657055	0.0276110103094621	ITGB5/PDGFRB/ITGA1	3
MD73	hsa05200	Pathways in cancer	4/15	531/7846	0.0155427431982995	0.0481994691163271	0.0300275962271426	EDNRA/PDGFRB/COL4A2/COL4A1	4
MD74	hsa05012	Parkinson disease	14/19	141/7846	2.04988241555373e-21	4.09976483110746e-20	2.15777096374077e-20	PARK7/UQCRB/MT-ATP8/MT-ND6/MT-ND3/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ND5/MT-CO1/MT-CYB/MT-ATP6/MT-ND4	14
MD74	hsa00190	Oxidative phosphorylation	13/19	132/7846	1.18215363647772e-19	1.18215363647772e-18	6.2218612446196e-19	UQCRB/MT-ATP8/MT-ND6/MT-ND3/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ND5/MT-CO1/MT-CYB/MT-ATP6/MT-ND4	13
MD74	hsa04714	Thermogenesis	13/19	230/7846	1.95841023698316e-16	1.30560682465544e-15	6.87161486660758e-16	UQCRB/MT-ATP8/MT-ND6/MT-ND3/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ND5/MT-CO1/MT-CYB/MT-ATP6/MT-ND4	13
MD74	hsa05010	Alzheimer disease	7/19	170/7846	8.0196192473412e-08	4.0098096236706e-07	2.11042611772137e-07	UQCRB/MT-ATP8/MT-CO3/MT-CO2/MT-CO1/MT-CYB/MT-ATP6	7
MD74	hsa05016	Huntington disease	7/19	192/7846	1.8509992715217e-07	7.40399708608679e-07	3.89684057162462e-07	UQCRB/MT-ATP8/MT-CO3/MT-CO2/MT-CO1/MT-CYB/MT-ATP6	7
MD74	hsa04723	Retrograde endocannabinoid signaling	6/19	147/7846	8.66668217832404e-07	2.88889405944135e-06	1.52047055760071e-06	MT-ND6/MT-ND3/MT-ND1/MT-ND2/MT-ND5/MT-ND4	6
MD74	hsa04260	Cardiac muscle contraction	5/19	85/7846	1.36780105972422e-06	3.90800302778348e-06	2.05684369883341e-06	UQCRB/MT-CO3/MT-CO2/MT-CO1/MT-CYB	5
MD74	hsa01100	Metabolic pathways	13/19	1488/7846	3.3802655790582e-06	8.4506639476455e-06	4.44771786718184e-06	UQCRB/MT-ATP8/MT-ND6/MT-ND3/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ND5/MT-CO1/MT-CYB/MT-ATP6/MT-ND4	13
MD74	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	5/19	150/7846	2.23775707658646e-05	4.97279350352548e-05	2.61725973869762e-05	UQCRB/MT-CO3/MT-CO2/MT-CO1/MT-CYB	5
MD75	hsa03010	Ribosome	33/48	150/7846	4.04810147968252e-47	1.65972160666983e-45	1.65972160666983e-45	RPS15A/RPL21/RPSA/RPL10/RPL23A/RPL7A/RPL13/RPL12/RPLP0/RPL35A/RPL30/RPL39/RPL14/RPL32/RPS29/RPL7/RPS10/RPS25/RPS3A/RPL15/RPS27A/RPS21/RPL22/RPS5/RPL6/RPL3/RPL27/RPS16/RPS11/RPS4X/RPL38/RPL10A/RPL19	33
MD76	hsa03010	Ribosome	23/23	150/7846	5.18859590204993e-41	5.18859590204993e-40	4.9155119072052e-40	RPL8/RPL36/RPS23/RPL26/RPL4/RPLP2/RPLP1/RPL13A/RPS24/RPL11/RPL5/RPS3/RPL31/RPS17/RPL37A/RPS20/RPS12/RPL34/RPL23/RPL27A/RPS18/RPS6/RPL9	23
MD79	hsa04540	Gap junction	3/9	88/7846	0.000109083164817932	0.00556324140571452	0.00424850220869839	PDGFRA/GUCY1A3/GUCY1B3	3
MD80	hsa04514	Cell adhesion molecules (CAMs)	4/20	144/7846	0.000419435143079194	0.0264244140139892	0.0238415765539752	ITGA8/VCAN/NTNG1/VCAM1	4
MD80	hsa04360	Axon guidance	4/20	183/7846	0.00103540442240733	0.0326152393058309	0.0294272835842083	CXCL12/NTNG1/SEMA5A/EPHA7	4
MD82	hsa04510	Focal adhesion	4/18	201/7846	0.000964692710367691	0.0108234091954555	0.00699119732720807	LAMA4/COL4A1/FN1/MYLK	4
MD82	hsa04512	ECM-receptor interaction	3/18	88/7846	0.000984946326491571	0.0108234091954555	0.00699119732720807	LAMA4/COL4A1/FN1	3
MD82	hsa05205	Proteoglycans in cancer	4/18	206/7846	0.00105745385240342	0.0108234091954555	0.00699119732720807	SDC2/GPC3/FN1/TIMP3	4
MD82	hsa05222	Small cell lung cancer	3/18	94/7846	0.00119280438826048	0.0108234091954555	0.00699119732720807	LAMA4/COL4A1/FN1	3
MD82	hsa04974	Protein digestion and absorption	3/18	95/7846	0.00122993286311994	0.0108234091954555	0.00699119732720807	COL4A1/COL12A1/COL21A1	3
MD82	hsa05146	Amoebiasis	3/18	102/7846	0.00151043948504933	0.0110765562236951	0.00715471335023368	LAMA4/COL4A1/FN1	3
MD82	hsa04270	Vascular smooth muscle contraction	3/18	132/7846	0.00315691114103931	0.0198434414579614	0.0128175339560995	CALD1/ACTA2/MYLK	3
MD82	hsa05200	Pathways in cancer	5/18	531/7846	0.00570178651721086	0.0313598258446597	0.0202563468374596	LAMA4/COL4A1/FN1/PTGER3/F2R	5
MD82	hsa04151	PI3K-Akt signaling pathway	4/18	355/7846	0.00761196817889953	0.0372140666523977	0.0240377942491564	LAMA4/COL4A1/FN1/F2R	4
MD82	hsa04020	Calcium signaling pathway	3/18	191/7846	0.00884980523434499	0.038939143031118	0.0251520780344542	PTGER3/MYLK/F2R	3
MD82	hsa04810	Regulation of actin cytoskeleton	3/18	215/7846	0.0122167222004518	0.048866888801807	0.0315647367858562	FN1/MYLK/F2R	3
MD84	hsa04141	Protein processing in endoplasmic reticulum	16/81	166/7846	7.97166882906961e-12	1.46678706454881e-09	1.11603363606975e-09	HSPA2/SKP1/DDIT3/ATF4/HSPA1A/HSPA1B/HSP90AB1/HSPA8/DNAJB1/HSPH1/HSP90AA1/PPP1R15A/DNAJA1/HERPUD1/HSPA5/HSP90B1	16
MD84	hsa03040	Spliceosome	12/81	135/7846	1.0591350142597e-08	9.74404213118923e-07	7.41394509981789e-07	HSPA2/SRSF2/SRSF6/SRSF3/SRSF7/HNRNPU/TRA2B/DDX5/HSPA1A/HSPA1B/HSPA8/EIF4A3	12
MD84	hsa04915	Estrogen signaling pathway	11/81	139/7846	1.52614083373717e-07	9.36033044692131e-06	7.12199055744013e-06	HSPA2/CALM1/ATF4/HSPA1A/HSPA1B/HSP90AB1/HSPA8/HSP90AA1/FOS/JUN/HSP90B1	11
MD84	hsa04612	Antigen processing and presentation	8/81	68/7846	4.06774425527514e-07	1.87116235742656e-05	1.4237104893463e-05	HSPA2/HLA-E/HSPA1A/HSPA1B/HSP90AB1/HSPA8/HSP90AA1/HSPA5	8
MD84	hsa05134	Legionellosis	7/81	57/7846	1.67694405771376e-06	6.17115413238665e-05	4.69544336159854e-05	HSPA2/CLK1/NFKBIA/HSPD1/HSPA1A/HSPA1B/HSPA8	7
MD84	hsa04657	IL-17 signaling pathway	8/81	94/7846	4.93458320597573e-06	0.000151327218316589	0.0001151402748061	NFKBIA/JUND/HSP90AB1/HSP90AA1/FOSB/FOS/JUN/HSP90B1	8
MD84	hsa04010	MAPK signaling pathway	13/81	295/7846	8.67149172409177e-06	0.000227936353890412	0.000173429834481835	HSPA2/DUSP5/DDIT3/GADD45B/ATF4/NR4A1/JUND/HSPA1A/HSPA1B/HSPA8/FOS/JUN/DUSP1	13
MD84	hsa04210	Apoptosis	9/81	138/7846	1.10637435522671e-05	0.000254466101702144	0.000193615512164675	DDIT3/GADD45B/TUBA1A/ATF4/LMNA/NFKBIA/MCL1/FOS/JUN	9
MD84	hsa05031	Amphetamine addiction	6/81	69/7846	7.16938970449525e-05	0.00146574189514125	0.00111523839847704	SIRT1/CALM1/ATF4/FOSB/FOS/JUN	6
MD84	hsa05418	Fluid shear stress and atherosclerosis	8/81	140/7846	9.02968644723392e-05	0.00166146230629104	0.00126415610261275	CALM1/KLF2/HSP90AB1/HSP90AA1/FOS/JUN/DUSP1/HSP90B1	8
MD84	hsa04668	TNF signaling pathway	7/81	114/7846	0.000162841826207844	0.00272389963838575	0.00207253233355438	ATF4/NFKBIA/IRF1/SOCS3/FOS/JUNB/JUN	7
MD84	hsa04380	Osteoclast differentiation	7/81	127/7846	0.000317618888190131	0.00487015628558201	0.00370555369555153	NFKBIA/JUND/FOSB/SOCS3/FOS/JUNB/JUN	7
MD84	hsa04213	Longevity regulating pathway - multiple species	5/81	64/7846	0.000490129692408598	0.00673907869558336	0.0051275598770743	HSPA2/SIRT1/HSPA1A/HSPA1B/HSPA8	5
MD84	hsa05215	Prostate cancer	6/81	99/7846	0.000524225981126039	0.00673907869558336	0.0051275598770743	ATF4/NFKBIA/HSP90AB1/HSP90AA1/CDKN1A/HSP90B1	6
MD84	hsa05162	Measles	7/81	140/7846	0.000573393929110843	0.00673907869558336	0.0051275598770743	HSPA2/NFKBIA/HSPA1A/HSPA1B/HSPA8/FOS/JUN	7
MD84	hsa05202	Transcriptional misregulation in cancer	8/81	184/7846	0.000586006843094205	0.00673907869558336	0.0051275598770743	DDIT3/ID2/GADD45B/H3F3B/NR4A3/DDX5/CDKN1A/NFKBIZ	8
MD84	hsa04928	Parathyroid hormone synthesis, secretion and action	6/81	106/7846	0.00075371672841628	0.00815787517815267	0.00620707893989877	ATF4/NR4A2/JUND/CDKN1A/EGR1/FOS	6
MD84	hsa05203	Viral carcinogenesis	8/81	202/7846	0.00107976982668805	0.0110376471172556	0.00839820976312927	ATF4/DDX3X/YWHAG/NFKBIA/EGR3/HLA-E/CDKN1A/JUN	8
MD84	hsa05161	Hepatitis B	7/81	164/7846	0.00145649724436123	0.014105025945393	0.0107320849584512	ATF4/DDX3X/NFKBIA/EGR3/CDKN1A/FOS/JUN	7
MD84	hsa05166	Human T-cell leukemia virus 1 infection	8/81	218/7846	0.00175813998632269	0.0161748878741687	0.0123069799042588	ATF4/NFKBIA/HLA-E/CDKN1A/EGR1/FOS/ZFP36/JUN	8
MD84	hsa05167	Kaposi sarcoma-associated herpesvirus infection	7/81	188/7846	0.00316192070094713	0.026589466138457	0.0202311155401303	CALM1/NFKBIA/HLA-E/CDKN1A/FOS/ZFP36/JUN	7
MD84	hsa04925	Aldosterone synthesis and secretion	5/81	97/7846	0.00317917529916333	0.026589466138457	0.0202311155401303	CALM1/ATF4/NR4A1/ATP1B3/NR4A2	5
MD84	hsa04659	Th17 cell differentiation	5/81	105/7846	0.00446829016045683	0.0356667128297883	0.0271377162835346	NFKBIA/HSP90AB1/HSP90AA1/FOS/JUN	5
MD84	hsa04625	C-type lectin receptor signaling pathway	5/81	106/7846	0.00465217993432022	0.0356667128297883	0.0271377162835346	CALM1/NFKBIA/EGR3/IRF1/JUN	5
MD84	hsa05145	Toxoplasmosis	5/81	110/7846	0.00544191869141916	0.0387073366230461	0.0294512343871003	HSPA2/NFKBIA/HSPA1A/HSPA1B/HSPA8	5
MD84	hsa05020	Prion diseases	3/81	35/7846	0.00546951495760434	0.0387073366230461	0.0294512343871003	HSPA1A/EGR1/HSPA5	3
MD84	hsa04218	Cellular senescence	6/81	160/7846	0.00603161030341459	0.0411043072528994	0.0312750163880757	SIRT1/CALM1/GADD45B/ZFP36L1/HLA-E/CDKN1A	6
MD84	hsa04918	Thyroid hormone synthesis	4/81	74/7846	0.00701815304704365	0.0461192914520011	0.0350907652352182	ATF4/ATP1B3/HSPA5/HSP90B1	4
MD84	hsa05133	Pertussis	4/81	76/7846	0.00770509557896844	0.0488875029837997	0.0371970131398476	CALM1/IRF1/FOS/JUN	4
MD85	hsa04512	ECM-receptor interaction	7/51	88/7846	1.36115616324401e-06	0.000164699895752525	0.000156174759782734	THBS2/TNC/COL1A2/COL1A1/FRAS1/COL6A3/COL9A1	7
MD85	hsa04350	TGF-beta signaling pathway	6/51	94/7846	2.93755577058241e-05	0.00125846580970313	0.00119332556118001	BMP4/DCN/FST/GREM1/LTBP1/BMP6	6
MD85	hsa04974	Protein digestion and absorption	6/51	95/7846	3.12016316455323e-05	0.00125846580970313	0.00119332556118001	ELN/COL3A1/COL1A2/COL1A1/COL6A3/COL9A1	6
MD85	hsa00830	Retinol metabolism	5/51	66/7846	6.29332531662127e-05	0.00190373090827793	0.00180519068292557	LRAT/ADH1B/CYP26B1/DHRS3/ALDH1A1	5
MD85	hsa04510	Focal adhesion	6/51	201/7846	0.00180823424788126	0.0354056449469032	0.0335729908587425	THBS2/TNC/COL1A2/COL1A1/COL6A3/COL9A1	6
MD85	hsa04151	PI3K-Akt signaling pathway	8/51	355/7846	0.00187574348048251	0.0354056449469032	0.0335729908587425	FGF10/THBS2/TNC/COL1A2/COL1A1/CHRM2/COL6A3/COL9A1	8
MD85	hsa05205	Proteoglycans in cancer	6/51	206/7846	0.00204826045147374	0.0354056449469032	0.0335729908587425	LUM/DCN/TWIST1/FZD7/COL1A2/COL1A1	6
MD86	hsa04141	Protein processing in endoplasmic reticulum	3/10	166/7846	0.00100050210288897	0.0104017547128714	0.00638704236755259	CKAP4/RRBP1/SSR1	3
MD88	hsa00190	Oxidative phosphorylation	10/12	132/7846	8.26362221504728e-17	8.97383521725046e-16	NA	MT-ND6/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ATP6/MT-CO1/MT-CYB/MT-ND4/MT-ND5	10
MD88	hsa05012	Parkinson disease	10/12	141/7846	1.63160640313645e-16	8.97383521725046e-16	NA	MT-ND6/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ATP6/MT-CO1/MT-CYB/MT-ND4/MT-ND5	10
MD88	hsa04714	Thermogenesis	10/12	230/7846	2.42220004846058e-14	8.8814001776888e-14	NA	MT-ND6/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ATP6/MT-CO1/MT-CYB/MT-ND4/MT-ND5	10
MD88	hsa04723	Retrograde endocannabinoid signaling	5/12	147/7846	1.53670739108782e-06	4.22594532549151e-06	NA	MT-ND6/MT-ND1/MT-ND2/MT-ND4/MT-ND5	5
MD88	hsa01100	Metabolic pathways	10/12	1488/7846	2.66183807033363e-06	5.78136612832917e-06	NA	MT-ND6/MT-ND1/MT-CO3/MT-CO2/MT-ND2/MT-ATP6/MT-CO1/MT-CYB/MT-ND4/MT-ND5	10
MD88	hsa05010	Alzheimer disease	5/12	170/7846	3.1534724336341e-06	5.78136612832917e-06	NA	MT-CO3/MT-CO2/MT-ATP6/MT-CO1/MT-CYB	5
MD88	hsa05016	Huntington disease	5/12	192/7846	5.73859821152542e-06	8.17396976354082e-06	NA	MT-CO3/MT-CO2/MT-ATP6/MT-CO1/MT-CYB	5
MD88	hsa04260	Cardiac muscle contraction	4/12	85/7846	5.94470528257514e-06	8.17396976354082e-06	NA	MT-CO3/MT-CO2/MT-CO1/MT-CYB	4
MD88	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	4/12	150/7846	5.63846773172842e-05	6.8914605610014e-05	NA	MT-CO3/MT-CO2/MT-CO1/MT-CYB	4
MD89	hsa04974	Protein digestion and absorption	7/8	95/7846	2.416705318908e-13	7.00844542483321e-12	4.32463057067748e-12	COL5A1/COL1A1/COL4A1/COL3A1/COL6A3/COL5A2/COL4A2	7
MD89	hsa04512	ECM-receptor interaction	5/8	88/7846	8.63289551247438e-09	1.25176984930879e-07	7.72416966905603e-08	COL1A1/ITGB1/COL4A1/COL6A3/COL4A2	5
MD89	hsa04510	Focal adhesion	5/8	201/7846	5.5245630801727e-07	5.34041097750028e-06	3.29535341624336e-06	COL1A1/ITGB1/COL4A1/COL6A3/COL4A2	5
MD89	hsa04933	AGE-RAGE signaling pathway in diabetic complications	4/8	102/7846	1.81112024028972e-06	1.05044973936804e-05	6.481904017879e-06	COL1A1/COL4A1/COL3A1/COL4A2	4
MD89	hsa05146	Amoebiasis	4/8	102/7846	1.81112024028972e-06	1.05044973936804e-05	6.481904017879e-06	COL1A1/COL4A1/COL3A1/COL4A2	4
MD89	hsa04926	Relaxin signaling pathway	4/8	131/7846	4.93415406178009e-06	2.38484112986038e-05	1.47158980789933e-05	COL1A1/COL4A1/COL3A1/COL4A2	4
MD89	hsa05165	Human papillomavirus infection	5/8	332/7846	6.63755705665962e-06	2.74984506633041e-05	1.69681909719118e-05	COL1A1/ITGB1/COL4A1/COL6A3/COL4A2	5
MD89	hsa04151	PI3K-Akt signaling pathway	5/8	355/7846	9.22609526719444e-06	3.34445953435798e-05	2.06373183608297e-05	COL1A1/ITGB1/COL4A1/COL6A3/COL4A2	5
MD89	hsa05222	Small cell lung cancer	3/8	94/7846	8.92991648238959e-05	0.000287741753321442	0.000177553894971489	ITGB1/COL4A1/COL4A2	3
MD89	hsa04611	Platelet activation	3/8	125/7846	0.000208544595471429	0.000604779326867144	0.000373185065580452	COL1A1/ITGB1/COL3A1	3
MD89	hsa05200	Pathways in cancer	3/8	531/7846	0.0133516845263082	0.035199895569358	0.0217204437270086	ITGB1/COL4A1/COL4A2	3
MD91	hsa04510	Focal adhesion	11/36	201/7846	8.14523594798161e-10	1.05888067323761e-07	8.05949662221338e-08	THBS2/PDGFRA/PIK3R1/PDGFD/COL6A6/TNR/LAMB1/LAMC1/LAMA4/COL6A5/COL1A2	11
MD91	hsa04512	ECM-receptor interaction	8/36	88/7846	4.24606873619392e-09	2.75994467852605e-07	2.10068663790647e-07	THBS2/COL6A6/TNR/LAMB1/LAMC1/LAMA4/COL6A5/COL1A2	8
MD91	hsa04151	PI3K-Akt signaling pathway	12/36	355/7846	2.86550277633436e-08	1.24171786974489e-06	9.45113196405017e-07	THBS2/PDGFRA/PIK3R1/F2R/PDGFD/COL6A6/TNR/LAMB1/LAMC1/LAMA4/COL6A5/COL1A2	12
MD91	hsa05165	Human papillomavirus infection	11/36	332/7846	1.53352530061102e-07	4.98395722698581e-06	3.7934573225641e-06	THBS2/WNT4/JAG1/PIK3R1/COL6A6/TNR/LAMB1/LAMC1/LAMA4/COL6A5/COL1A2	11
MD91	hsa05200	Pathways in cancer	12/36	531/7846	2.27354803039282e-06	5.91122487902134e-05	4.49923189172474e-05	WNT4/JAG1/PTCH1/BMP4/HHIP/PDGFRA/PIK3R1/F2R/DLL1/LAMB1/LAMC1/LAMA4	12
MD91	hsa05215	Prostate cancer	5/36	99/7846	7.98869305796551e-05	0.00171069339892318	0.00130206623075934	PDGFRA/PIK3R1/PLAT/ZEB1/PDGFD	5
MD91	hsa05146	Amoebiasis	5/36	102/7846	9.21142599420175e-05	0.00171069339892318	0.00130206623075934	PIK3R1/LAMB1/LAMC1/LAMA4/COL1A2	5
MD91	hsa05217	Basal cell carcinoma	4/36	63/7846	0.000183400860452094	0.00298026398234652	0.00226837906348642	WNT4/PTCH1/BMP4/HHIP	4
MD91	hsa04610	Complement and coagulation cascades	4/36	85/7846	0.000580248487079233	0.00838136703558893	0.00637934009186526	F3/F2R/PLAT/A2M	4
MD91	hsa05222	Small cell lung cancer	4/36	94/7846	0.000848639431507648	0.0110323126095994	0.00839706384860199	PIK3R1/LAMB1/LAMC1/LAMA4	4
MD91	hsa04550	Signaling pathways regulating pluripotency of stem cells	4/36	141/7846	0.00376769606938368	0.0427124335374773	0.0325098684414807	WNT4/BMP4/INHBA/PIK3R1	4
MD91	hsa04072	Phospholipase D signaling pathway	4/36	149/7846	0.00458836725331123	0.0427124335374773	0.0325098684414807	PDGFRA/PIK3R1/F2R/PDGFD	4
MD91	hsa05224	Breast cancer	4/36	149/7846	0.00458836725331123	0.0427124335374773	0.0325098684414807	WNT4/JAG1/PIK3R1/DLL1	4
MD91	hsa05218	Melanoma	3/36	74/7846	0.00459980053480524	0.0427124335374773	0.0325098684414807	PDGFRA/PIK3R1/PDGFD	3
MD92	hsa03010	Ribosome	43/45	150/7846	1.70738365710887e-74	2.21959875424154e-73	2.15669514582174e-73	RPL41/RPLP1/RPL32/RPLP0/RPL39/RPL30/RPS5/RPL13/RPL22/RPS11/RPL7/RPL19/RPL27/RPS16/RPS4X/RPL10A/RPL6/RPS24/RPL26/RPLP2/RPS27A/RPL4/RPL31/RPL13A/RPL11/RPL3/RPS18/RPL8/RPL37A/RPL27A/RPS6/RPL9/RPS12/RPS17/RPL23/RPL34/RPS23/RPS20/RPL5/RPS3/RPS15A/RPL38/RPL36	43
MD94	hsa03013	RNA transport	5/11	164/7846	1.56703981368795e-06	3.44748759011349e-05	2.63922494936918e-05	EIF3F/EIF3E/EIF2S3/PABPC1/EIF4B	5
MD95	hsa05205	Proteoglycans in cancer	5/28	206/7846	0.000713624448698742	0.044244715819322	0.0353056306198325	GPC3/LUM/DCN/WNT2B/FN1	5
MD97	hsa04612	Antigen processing and presentation	5/20	68/7846	5.905253000366e-07	4.7242024002928e-05	3.10802789492947e-05	CD74/HLA-C/HLA-A/HLA-B/CTSS	5
MD97	hsa04145	Phagosome	5/20	148/7846	2.75353934755265e-05	0.00110141573902106	0.000724615617777013	HLA-C/HLA-A/HLA-B/C1R/CTSS	5
MD97	hsa05330	Allograft rejection	3/20	35/7846	8.80194617101137e-05	0.00208308626129381	0.0013704514876933	HLA-C/HLA-A/HLA-B	3
MD97	hsa05332	Graft-versus-host disease	3/20	37/7846	0.000104154313064691	0.00208308626129381	0.0013704514876933	HLA-C/HLA-A/HLA-B	3
MD97	hsa04940	Type I diabetes mellitus	3/20	41/7846	0.00014196715766916	0.00227147452270656	0.00149439113335958	HLA-C/HLA-A/HLA-B	3
MD97	hsa05320	Autoimmune thyroid disease	3/20	50/7846	0.000257234752225534	0.00342979669634045	0.00225644519496082	HLA-C/HLA-A/HLA-B	3
MD97	hsa04144	Endocytosis	5/20	247/7846	0.000312327552427957	0.0035694577420338	0.00234832746186434	PML/LDLR/HLA-C/HLA-A/HLA-B	5
MD97	hsa05416	Viral myocarditis	3/20	57/7846	0.000379667886514482	0.00372831238292617	0.00245283709403037	HLA-C/HLA-A/HLA-B	3
MD97	hsa04514	Cell adhesion molecules (CAMs)	4/20	144/7846	0.000419435143079194	0.00372831238292617	0.00245283709403037	NECTIN2/HLA-C/HLA-A/HLA-B	4
MD97	hsa05168	Herpes simplex virus 1 infection	6/20	489/7846	0.00103843190714848	0.00830745525718785	0.00546543109025516	PML/CD74/BIRC3/HLA-C/HLA-A/HLA-B	6
MD97	hsa05167	Kaposi sarcoma-associated herpesvirus infection	4/20	188/7846	0.00114485682452023	0.00832623145105623	0.0054777838493791	IL6ST/HLA-C/HLA-A/HLA-B	4
MD97	hsa05169	Epstein-Barr virus infection	4/20	199/7846	0.00141401173730505	0.00919701663051681	0.00605066883586632	RELB/HLA-C/HLA-A/HLA-B	4
MD97	hsa05203	Viral carcinogenesis	4/20	202/7846	0.00149451520245898	0.00919701663051681	0.00605066883586632	IL6ST/HLA-C/HLA-A/HLA-B	4
MD97	hsa05166	Human T-cell leukemia virus 1 infection	4/20	218/7846	0.00197900920329962	0.011308624018855	0.00743988422293091	RELB/HLA-C/HLA-A/HLA-B	4
MD97	hsa04650	Natural killer cell mediated cytotoxicity	3/20	125/7846	0.00369155410786258	0.0196882885752671	0.0129528214310968	HLA-C/HLA-A/HLA-B	3
MD97	hsa04210	Apoptosis	3/20	138/7846	0.00487459744016229	0.0243729872008115	0.0160348600005339	BIRC3/CTSS/CTSK	3
MD97	hsa04218	Cellular senescence	3/20	160/7846	0.00735286859713466	0.0309594467247775	0.0203680570557747	HLA-C/HLA-A/HLA-B	3
MD98	hsa04141	Protein processing in endoplasmic reticulum	13/82	166/7846	1.33810563663067e-08	2.44873331503412e-06	1.61981208644765e-06	DDIT3/HSPA5/HERPUD1/HSPA8/HSPA1A/HSPA1B/HSP90AB1/HSP90AA1/HSPH1/DNAJB1/XBP1/PPP1R15A/DNAJA1	13
MD98	hsa04657	IL-17 signaling pathway	10/82	94/7846	3.94188419122937e-08	3.60682403497488e-06	2.38587727363883e-06	CXCL2/HSP90AB1/HSP90AA1/TNFAIP3/CCL2/JUND/NFKBIA/JUN/FOS/FOSB	10
MD98	hsa04668	TNF signaling pathway	10/82	114/7846	2.50734683214671e-07	1.52948156760949e-05	1.01173644104165e-05	ICAM1/CXCL2/JUNB/TNFAIP3/CCL2/IRF1/NFKBIA/JUN/FOS/SOCS3	10
MD98	hsa04612	Antigen processing and presentation	8/82	68/7846	4.47677433469116e-07	2.04812425812121e-05	1.35481328549864e-05	HLA-E/TAP1/HSPA5/HSPA8/HSPA1A/HSPA1B/HSP90AB1/HSP90AA1	8
MD98	hsa05169	Epstein-Barr virus infection	12/82	199/7846	8.88753990629436e-07	3.25283960570373e-05	2.15172018783969e-05	MYC/ICAM1/NFKBIE/HLA-E/TAP1/CYCS/GADD45A/GADD45B/TNFAIP3/CDKN1A/NFKBIA/JUN	12
MD98	hsa05134	Legionellosis	7/82	57/7846	1.8232111298906e-06	5.56079394616632e-05	3.67840841995471e-05	CYCS/CXCL2/HSPD1/HSPA8/HSPA1A/HSPA1B/NFKBIA	7
MD98	hsa05167	Kaposi sarcoma-associated herpesvirus infection	11/82	188/7846	3.54882385221973e-06	9.27763949937442e-05	6.1370638045905e-05	MYC/ICAM1/HLA-E/CYCS/CXCL2/CALM1/CDKN1A/NFKBIA/JUN/FOS/ZFP36	11
MD98	hsa05161	Hepatitis B	10/82	164/7846	7.0858997807795e-06	0.000162089957485331	0.000107220851946006	YWHAZ/MYC/CYCS/DDX3X/EGR2/EGR3/CDKN1A/NFKBIA/JUN/FOS	10
MD98	hsa04010	MAPK signaling pathway	13/82	295/7846	9.96283083630999e-06	0.000187434512818586	0.000123986016532283	MYC/NR4A1/GADD45A/DDIT3/HSPA8/HSPA1A/HSPA1B/GADD45B/JUND/DUSP1/DUSP5/JUN/FOS	13
MD98	hsa03040	Spliceosome	9/82	135/7846	1.02423231048407e-05	0.000187434512818586	0.000123986016532283	SRSF5/TRA2B/HSPA8/HSPA1A/HSPA1B/SRSF3/SRSF7/EIF4A3/DDX5	9
MD98	hsa05210	Colorectal cancer	7/82	88/7846	3.37514797615695e-05	0.000561501890578838	0.000371427767711052	MYC/CYCS/GADD45A/GADD45B/CDKN1A/JUN/FOS	7
MD98	hsa05203	Viral carcinogenesis	10/82	202/7846	4.35902935541919e-05	0.000664751976701427	0.000439726645502814	YWHAZ/HLA-E/GTF2B/YWHAG/DDX3X/EGR2/EGR3/CDKN1A/NFKBIA/JUN	10
MD98	hsa04380	Osteoclast differentiation	8/82	127/7846	4.93715441820746e-05	0.000694999429639973	0.000459735026796646	FOSL2/JUNB/JUND/NFKBIA/JUN/FOS/FOSB/SOCS3	8
MD98	hsa05166	Human T-cell leukemia virus 1 infection	10/82	218/7846	8.29979654898632e-05	0.00100214275157121	0.000662907198335858	MYC/ICAM1/HLA-E/EGR2/CDKN1A/NFKBIA/JUN/FOS/EGR1/ZFP36	10
MD98	hsa04210	Apoptosis	8/82	138/7846	8.90778194877333e-05	0.00100214275157121	0.000662907198335858	CYCS/GADD45A/DDIT3/GADD45B/NFKBIA/JUN/MCL1/FOS	8
MD98	hsa04915	Estrogen signaling pathway	8/82	139/7846	9.37248938685504e-05	0.00100214275157121	0.000662907198335858	CALM1/HSPA8/HSPA1A/HSPA1B/HSP90AB1/HSP90AA1/JUN/FOS	8
MD98	hsa05162	Measles	8/82	140/7846	9.8571418187332e-05	0.00100214275157121	0.000662907198335858	CYCS/HSPA8/HSPA1A/HSPA1B/TNFAIP3/NFKBIA/JUN/FOS	8
MD98	hsa05418	Fluid shear stress and atherosclerosis	8/82	140/7846	9.8571418187332e-05	0.00100214275157121	0.000662907198335858	ICAM1/CALM1/HSP90AB1/HSP90AA1/CCL2/DUSP1/JUN/FOS	8
MD98	hsa05202	Transcriptional misregulation in cancer	9/82	184/7846	0.000118330725195193	0.00113971172161686	0.000753907667448599	FUS/MYC/GADD45A/DDIT3/GADD45B/H3F3B/CDKN1A/DDX5/NFKBIZ	9
MD98	hsa05222	Small cell lung cancer	6/82	94/7846	0.000424058812221334	0.0038801381318252	0.00256667175818176	MYC/CYCS/GADD45A/GADD45B/CDKN1A/NFKBIA	6
MD98	hsa04621	NOD-like receptor signaling pathway	8/82	180/7846	0.00055028565737215	0.00468339879644027	0.00309802048657251	CXCL2/HSP90AB1/HSP90AA1/TNFAIP3/CCL2/NAMPT/NFKBIA/JUN	8
MD98	hsa05216	Thyroid cancer	4/82	37/7846	0.00056303154929883	0.00468339879644027	0.00309802048657251	MYC/GADD45A/GADD45B/CDKN1A	4
MD98	hsa04659	Th17 cell differentiation	6/82	105/7846	0.000765197702320848	0.00608831215324848	0.00402735632800446	NFKBIE/HSP90AB1/HSP90AA1/NFKBIA/JUN/FOS	6
MD98	hsa04625	C-type lectin receptor signaling pathway	6/82	106/7846	0.000804424363161457	0.00613373576910611	0.00405740358612138	CALM1/EGR2/EGR3/IRF1/NFKBIA/JUN	6
MD98	hsa05145	Toxoplasmosis	6/82	110/7846	0.000977116396965053	0.00715249202578419	0.00473130044846236	PPIF/CYCS/HSPA8/HSPA1A/HSPA1B/NFKBIA	6
MD98	hsa05133	Pertussis	5/82	76/7846	0.00113988601509349	0.0080230438754657	0.00530716160873486	IRF8/CALM1/IRF1/JUN/FOS	5
MD98	hsa05160	Hepatitis C	7/82	157/7846	0.00121545556234905	0.00823808770036579	0.00544941090331934	YWHAZ/MYC/CYCS/YWHAG/CDKN1A/NFKBIA/SOCS3	7
MD98	hsa05220	Chronic myeloid leukemia	5/82	78/7846	0.0012815288491556	0.00837570640698121	0.00554044427266517	MYC/GADD45A/GADD45B/CDKN1A/NFKBIA	5
MD98	hsa04218	Cellular senescence	7/82	160/7846	0.0013568049372752	0.00856190701797796	0.00566361407574038	ZFP36L1/MYC/HLA-E/CALM1/GADD45A/GADD45B/CDKN1A	7
MD98	hsa04110	Cell cycle	6/82	124/7846	0.00181453469502697	0.0110686616396645	0.00732180666414392	YWHAZ/MYC/GADD45A/YWHAG/GADD45B/CDKN1A	6
MD98	hsa05164	Influenza A	7/82	170/7846	0.00192309167145479	0.0113524443831041	0.00750952605152126	KPNA2/ICAM1/CYCS/DNAJB1/CCL2/NFKBIA/SOCS3	7
MD98	hsa05163	Human cytomegalovirus infection	8/82	224/7846	0.00225591022476059	0.012778478359147	0.00845283296693645	MYC/HLA-E/TAP1/CYCS/CALM1/CCL2/CDKN1A/NFKBIA	8
MD98	hsa05323	Rheumatoid arthritis	5/82	89/7846	0.00230431576968224	0.012778478359147	0.00845283296693645	ICAM1/CXCL2/CCL2/JUN/FOS	5
MD98	hsa05213	Endometrial cancer	4/82	60/7846	0.00346617093787308	0.0186561553420816	0.0123408562803531	MYC/GADD45A/GADD45B/CDKN1A	4
MD98	hsa04064	NF-kappa B signaling pathway	5/82	100/7846	0.00382302801334271	0.0199889750411919	0.0132225029032906	ICAM1/CXCL2/GADD45B/TNFAIP3/NFKBIA	5
MD98	hsa04933	AGE-RAGE signaling pathway in diabetic complications	5/82	102/7846	0.00416152539792154	0.0211544207727678	0.0139934333555841	ICAM1/CCL2/PIM1/JUN/EGR1	5
MD98	hsa05224	Breast cancer	6/82	149/7846	0.00453797117291323	0.0224445601254898	0.01484684736515	MYC/GADD45A/GADD45B/CDKN1A/JUN/FOS	6
MD98	hsa04928	Parathyroid hormone synthesis, secretion and action	5/82	106/7846	0.00490203419218766	0.0236071646623774	0.0156158983961657	NR4A2/JUND/CDKN1A/FOS/EGR1	5
MD98	hsa05020	Prion diseases	3/82	35/7846	0.00565999647030438	0.0261912807779235	0.0173252648229002	HSPA5/HSPA1A/EGR1	3
MD98	hsa05031	Amphetamine addiction	4/82	69/7846	0.00572487011539312	0.0261912807779235	0.0173252648229002	CALM1/JUN/FOS/FOSB	4
MD98	hsa05170	Human immunodeficiency virus 1 infection	7/82	212/7846	0.00651735763497593	0.0283188193250006	0.0187326098497272	HLA-E/TAP1/CYCS/CALM1/NFKBIA/JUN/FOS	7
MD98	hsa04115	p53 signaling pathway	4/82	72/7846	0.00665414880314223	0.0283188193250006	0.0187326098497272	CYCS/GADD45A/GADD45B/CDKN1A	4
MD98	hsa04917	Prolactin signaling pathway	4/82	72/7846	0.00665414880314223	0.0283188193250006	0.0187326098497272	CISH/IRF1/FOS/SOCS3	4
MD98	hsa04630	JAK-STAT signaling pathway	6/82	164/7846	0.00719948354600349	0.0299433065663327	0.019807191573933	MYC/CISH/PIM1/CDKN1A/MCL1/SOCS3	6
MD98	hsa05214	Glioma	4/82	77/7846	0.00841616212266544	0.0342257259655061	0.0226399682831936	CALM1/GADD45A/GADD45B/CDKN1A	4
MD98	hsa05200	Pathways in cancer	12/82	531/7846	0.00869170371638983	0.0345778647847682	0.0228729045168153	MYC/CYCS/CALM1/GADD45A/HSP90AB1/HSP90AA1/GADD45B/PIM1/CDKN1A/NFKBIA/JUN/FOS	12
MD98	hsa03018	RNA degradation	4/82	79/7846	0.0091988727187133	0.035816887394139	0.0236925053225539	TOB1/BTG1/HSPD1/BTG2	4
MD98	hsa04662	B cell receptor signaling pathway	4/82	81/7846	0.0100276942211275	0.0382305842180486	0.0252891411278435	NFKBIE/NFKBIA/JUN/FOS	4
MD99	hsa04210	Apoptosis	4/21	138/7846	0.00043455820809722	0.0206822602896973	0.0184902687521446	TUBA1B/TUBA1A/ATF4/TUBA1C	4
MD99	hsa04145	Phagosome	4/21	148/7846	0.000566637268210884	0.0206822602896973	0.0184902687521446	TUBA1B/TUBA1A/TFRC/TUBA1C	4
MD99	hsa04540	Gap junction	3/21	88/7846	0.00156681653185329	0.0381258689417634	0.0340851315701418	TUBA1B/TUBA1A/TUBA1C	3
MD101	hsa00190	Oxidative phosphorylation	10/12	132/7846	8.26362221504728e-17	8.97383521725046e-16	NA	MT-ND1/MT-ATP8/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ATP6/MT-ND5/MT-CO1/MT-ND4	10
MD101	hsa05012	Parkinson disease	10/12	141/7846	1.63160640313645e-16	8.97383521725046e-16	NA	MT-ND1/MT-ATP8/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ATP6/MT-ND5/MT-CO1/MT-ND4	10
MD101	hsa04714	Thermogenesis	10/12	230/7846	2.42220004846058e-14	8.8814001776888e-14	NA	MT-ND1/MT-ATP8/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ATP6/MT-ND5/MT-CO1/MT-ND4	10
MD101	hsa05010	Alzheimer disease	6/12	170/7846	7.86054879345614e-08	2.16165091820044e-07	NA	MT-ATP8/MT-CO2/MT-CO3/MT-CYB/MT-ATP6/MT-CO1	6
MD101	hsa05016	Huntington disease	6/12	192/7846	1.6243165861687e-07	3.57349648957114e-07	NA	MT-ATP8/MT-CO2/MT-CO3/MT-CYB/MT-ATP6/MT-CO1	6
MD101	hsa01100	Metabolic pathways	10/12	1488/7846	2.66183807033363e-06	4.88003646227833e-06	NA	MT-ND1/MT-ATP8/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ATP6/MT-ND5/MT-CO1/MT-ND4	10
MD101	hsa04260	Cardiac muscle contraction	4/12	85/7846	5.94470528257514e-06	9.34167972976093e-06	NA	MT-CO2/MT-CO3/MT-CYB/MT-CO1	4
MD101	hsa04723	Retrograde endocannabinoid signaling	4/12	147/7846	5.20930752498768e-05	6.8914605610014e-05	NA	MT-ND1/MT-ND2/MT-ND5/MT-ND4	4
MD101	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	4/12	150/7846	5.63846773172842e-05	6.8914605610014e-05	NA	MT-CO2/MT-CO3/MT-CYB/MT-CO1	4
MD104	hsa03010	Ribosome	4/7	150/7846	4.29657692013949e-06	2.5779461520837e-05	2.26135627375763e-05	RPLP0/RPL35/RPS7/RPL15	4
MD105	hsa03010	Ribosome	5/6	150/7846	1.41230343833885e-08	4.23691031501656e-08	2.97327039650285e-08	RPL30/RPL13/RPS21/RPS3A/RPL7	5
MD106	hsa03010	Ribosome	37/38	150/7846	8.25870681341361e-65	1.07363188574377e-63	1.04320507116804e-63	RPS15A/RPL41/RPL32/RPL26/RPS16/RPL35A/RPL27/RPL38/RPL8/RPS4X/RPS23/RPLP2/RPL19/RPLP1/RPL13A/RPL36/RPS27A/RPS24/RPL22/RPS18/RPL31/RPL37A/RPL27A/RPS20/RPS3/RPS12/RPS17/RPL34/RPL23/RPL5/RPS6/RPL6/RPL3/RPL4/RPL9/RPL11/RPL10A	37
MD107	hsa04974	Protein digestion and absorption	7/19	95/7846	1.36557777515139e-09	6.00854221066613e-08	4.88733098475236e-08	COL5A1/COL5A2/COL3A1/COL1A2/COL1A1/COL14A1/COL12A1	7
MD107	hsa04512	ECM-receptor interaction	3/19	88/7846	0.00116018139958138	0.0156358902033493	0.0127181882036813	THBS2/COL1A2/COL1A1	3
MD107	hsa05205	Proteoglycans in cancer	4/19	206/7846	0.00131214876153906	0.0156358902033493	0.0127181882036813	COL1A2/COL1A1/GPC3/LUM	4
MD107	hsa04933	AGE-RAGE signaling pathway in diabetic complications	3/19	102/7846	0.00177680570492606	0.0156358902033493	0.0127181882036813	COL3A1/COL1A2/COL1A1	3
MD107	hsa05146	Amoebiasis	3/19	102/7846	0.00177680570492606	0.0156358902033493	0.0127181882036813	COL3A1/COL1A2/COL1A1	3
MD107	hsa04611	Platelet activation	3/19	125/7846	0.00317443848728806	0.0227824968157746	0.018531217505654	COL3A1/COL1A2/COL1A1	3
MD107	hsa04926	Relaxin signaling pathway	3/19	131/7846	0.00362448812978232	0.0227824968157746	0.018531217505654	COL3A1/COL1A2/COL1A1	3
MD112	hsa04540	Gap junction	4/15	88/7846	1.83539755603517e-05	0.00168856575155235	0.00135239819918381	TUBA1B/TUBA1A/TUBB/TUBA1C	4
MD112	hsa04145	Phagosome	4/15	148/7846	0.000141142774559521	0.00649256762973798	0.00519999695745605	TUBA1B/TUBA1A/TUBB/TUBA1C	4
MD112	hsa05130	Pathogenic Escherichia coli infection	4/15	200/7846	0.00044850430897188	0.0137541321418043	0.0110158953080813	TUBA1B/TUBA1A/TUBB/TUBA1C	4
MD112	hsa04210	Apoptosis	3/15	138/7846	0.0020746588817802	0.0475983651855226	0.0381222604460707	TUBA1B/TUBA1A/TUBA1C	3
MD112	hsa04218	Cellular senescence	3/15	160/7846	0.00316210275314989	0.0475983651855226	0.0381222604460707	CDK6/HIPK1/CALM1	3
MD112	hsa04530	Tight junction	3/15	169/7846	0.00369156305083345	0.0475983651855226	0.0381222604460707	TUBA1B/TUBA1A/TUBA1C	3
MD112	hsa05152	Tuberculosis	3/15	176/7846	0.00413898827700197	0.0475983651855226	0.0381222604460707	BCL10/CEBPB/CALM1	3
MD114	hsa04141	Protein processing in endoplasmic reticulum	15/100	166/7846	2.15618196098046e-09	4.16143118469229e-07	3.20022796313942e-07	DDIT3/ATF4/HSPA2/XBP1/HSPA5/HERPUD1/HSP90AB1/HSPA1A/HSPA1B/HSP90AA1/HSPH1/DNAJB1/PPP1R15A/DNAJA1/HSPA8	15
MD114	hsa03040	Spliceosome	13/100	135/7846	1.28738383272709e-08	1.24232539858164e-06	9.55374317971153e-07	BUD31/SRSF5/SRSF3/HSPA2/SRSF7/SRSF2/HNRNPU/DDX5/TRA2B/HSPA1A/HSPA1B/EIF4A3/HSPA8	13
MD114	hsa04612	Antigen processing and presentation	8/100	68/7846	2.06655929261417e-06	0.000132948647824845	0.000102240301845122	HSPA2/HLA-E/HSPA5/HSP90AB1/HSPA1A/HSPA1B/HSP90AA1/HSPA8	8
MD114	hsa04010	MAPK signaling pathway	15/100	295/7846	4.19861000995988e-06	0.000202582932980564	0.000155790529316932	DDIT3/ATF4/HSPA2/GADD45A/DUSP5/MYC/HSPA1A/HSPA1B/NR4A1/GADD45B/JUND/HSPA8/DUSP1/JUN/FOS	15
MD114	hsa05134	Legionellosis	7/100	57/7846	6.93994709032582e-06	0.000267881957686577	0.000206006850470724	HSPA2/CYCS/NFKBIA/HSPA1A/HSPA1B/HSPD1/HSPA8	7
MD114	hsa04915	Estrogen signaling pathway	10/100	139/7846	9.81038836543349e-06	0.000315567492421444	0.000242678027987039	HBEGF/ATF4/HSPA2/HSP90AB1/HSPA1A/HSPA1B/HSP90AA1/HSPA8/JUN/FOS	10
MD114	hsa05161	Hepatitis B	10/100	164/7846	4.15078748433494e-05	0.0011444314063952	0.000880091782392821	ATF4/CYCS/EGR2/NFKBIA/MYC/DDX3X/EGR3/CDKN1A/JUN/FOS	10
MD114	hsa04210	Apoptosis	9/100	138/7846	6.08272004426766e-05	0.00146745621067957	0.00112850463979176	DDIT3/ATF4/GADD45A/CYCS/NFKBIA/GADD45B/JUN/FOS/MCL1	9
MD114	hsa05202	Transcriptional misregulation in cancer	10/100	184/7846	0.000109631676465686	0.00233053012937463	0.00179222660617302	DDIT3/GADD45A/MLF1/MYC/DDX5/NR4A3/H3F3B/GADD45B/CDKN1A/NFKBIZ	10
MD114	hsa05210	Colorectal cancer	7/100	88/7846	0.000120752856444281	0.00233053012937463	0.00179222660617302	GADD45A/CYCS/MYC/GADD45B/CDKN1A/JUN/FOS	7
MD114	hsa04657	IL-17 signaling pathway	7/100	94/7846	0.000182949096810826	0.00320992506222631	0.00246849977515086	NFKBIA/HSP90AB1/HSP90AA1/JUND/JUN/FOSB/FOS	7
MD114	hsa04380	Osteoclast differentiation	8/100	127/7846	0.000202161009195276	0.0032514228978907	0.0025004124821521	NFKBIA/FOSL2/JUNB/JUND/SOCS3/JUN/FOSB/FOS	8
MD114	hsa05203	Viral carcinogenesis	10/100	202/7846	0.000235952805773329	0.00350299165494251	0.00269387413878862	ATF4/GTF2B/EGR2/NFKBIA/YWHAG/HLA-E/DDX3X/EGR3/CDKN1A/JUN	10
MD114	hsa04115	p53 signaling pathway	6/100	72/7846	0.000292002426897307	0.00402546202794144	0.00309566482650528	GADD45A/CYCS/CCNG2/THBS1/GADD45B/CDKN1A	6
MD114	hsa04928	Parathyroid hormone synthesis, secretion and action	7/100	106/7846	0.000384629911035585	0.00474267418012849	0.00364721603162322	HBEGF/ATF4/NR4A2/JUND/CDKN1A/EGR1/FOS	7
MD114	hsa05162	Measles	8/100	140/7846	0.000393175061565056	0.00474267418012849	0.00364721603162322	HSPA2/CYCS/NFKBIA/HSPA1A/HSPA1B/HSPA8/JUN/FOS	8
MD114	hsa05166	Human T-cell leukemia virus 1 infection	10/100	218/7846	0.000434624577951153	0.0049342672673278	0.00379455513876858	ATF4/EGR2/NFKBIA/MYC/HLA-E/CDKN1A/JUN/EGR1/FOS/ZFP36	10
MD114	hsa04668	TNF signaling pathway	7/100	114/7846	0.000597784307709197	0.00640957618821528	0.00492909867760215	ATF4/NFKBIA/JUNB/SOCS3/JUN/FOS/IRF1	7
MD114	hsa05216	Thyroid cancer	4/100	37/7846	0.00118818264179138	0.0117252208623797	0.00901694105042563	GADD45A/MYC/GADD45B/CDKN1A	4
MD114	hsa05222	Small cell lung cancer	6/100	94/7846	0.00121504879402899	0.0117252208623797	0.00901694105042563	GADD45A/CYCS/NFKBIA/MYC/GADD45B/CDKN1A	6
MD114	hsa04213	Longevity regulating pathway - multiple species	5/100	64/7846	0.00127908164353131	0.0117553693905497	0.00904012590164987	SIRT1/HSPA2/HSPA1A/HSPA1B/HSPA8	5
MD114	hsa04068	FoxO signaling pathway	7/100	132/7846	0.00142133075517205	0.0124689470794639	0.00958888212819418	SIRT1/PLK2/GADD45A/CCNG2/KLF2/GADD45B/CDKN1A	7
MD114	hsa05219	Bladder cancer	4/100	41/7846	0.00175234495823597	0.0144205873720661	0.0110897344939259	HBEGF/MYC/THBS1/CDKN1A	4
MD114	hsa05031	Amphetamine addiction	5/100	69/7846	0.0017932336628476	0.0144205873720661	0.0110897344939259	SIRT1/ATF4/JUN/FOSB/FOS	5
MD114	hsa05167	Kaposi sarcoma-associated herpesvirus infection	8/100	188/7846	0.00265769953911478	0.0201535548068372	0.0154985068326373	CYCS/NFKBIA/MYC/HLA-E/CDKN1A/JUN/FOS/ZFP36	8
MD114	hsa05145	Toxoplasmosis	6/100	110/7846	0.00271498665791589	0.0201535548068372	0.0154985068326373	HSPA2/CYCS/NFKBIA/HSPA1A/HSPA1B/HSPA8	6
MD114	hsa05220	Chronic myeloid leukemia	5/100	78/7846	0.00307849903514616	0.0220055671771559	0.0169227432341368	GADD45A/NFKBIA/MYC/GADD45B/CDKN1A	5
MD114	hsa03018	RNA degradation	5/100	79/7846	0.0032538328830148	0.022428205229352	0.0172477607708679	TOB1/BTG1/TOB2/HSPD1/BTG2	5
MD114	hsa05169	Epstein-Barr virus infection	8/100	199/7846	0.0037676558784122	0.0244196647455162	0.0187792349556465	GADD45A/CYCS/NFKBIA/MYC/HLA-E/GADD45B/CDKN1A/JUN	8
MD114	hsa05160	Hepatitis C	7/100	157/7846	0.00379580281018387	0.0244196647455162	0.0187792349556465	PPP2CB/CYCS/NFKBIA/MYC/YWHAG/CDKN1A/SOCS3	7
MD114	hsa05213	Endometrial cancer	4/100	60/7846	0.00701887509979166	0.0436981578793481	0.033604800987118	GADD45A/MYC/GADD45B/CDKN1A	4
MD116	hsa04810	Regulation of actin cytoskeleton	4/11	215/7846	0.000155536612325983	0.00715468416699523	0.00638518724285615	GNG12/CFL2/ENAH/FN1	4
MD117	hsa04270	Vascular smooth muscle contraction	10/44	132/7846	1.96884967925936e-09	1.5357027498223e-07	1.2020345410215e-07	PPP1R12A/MYL9/MRVI1/MYL6/CALD1/ACTG2/ACTA2/MYLK/MYH11/PPP1R12B	10
MD117	hsa04510	Focal adhesion	11/44	201/7846	8.68830087222905e-09	3.38843734016933e-07	2.65221816099624e-07	ILK/PPP1R12A/ACTN1/PARVA/COL4A1/MYL9/ITGA1/VCL/CAV1/MYLK/PPP1R12B	11
MD117	hsa05410	Hypertrophic cardiomyopathy (HCM)	5/44	90/7846	0.000135531553963812	0.00273016688913424	0.0021369727337353	DES/DMD/ITGA1/TPM2/TPM1	5
MD117	hsa04810	Regulation of actin cytoskeleton	7/44	215/7846	0.00017012166074027	0.00273016688913424	0.0021369727337353	PPP1R12A/ACTN1/MYL9/ITGA1/VCL/MYLK/PPP1R12B	7
MD117	hsa05414	Dilated cardiomyopathy (DCM)	5/44	95/7846	0.000175010698021425	0.00273016688913424	0.0021369727337353	DES/DMD/ITGA1/TPM2/TPM1	5
MD117	hsa04921	Oxytocin signaling pathway	5/44	153/7846	0.00155346197259794	0.0201950056437732	0.0158071569141545	PPP1R12A/MYL9/MYL6/MYLK/PPP1R12B	5
MD117	hsa05131	Shigellosis	6/44	236/7846	0.00188228085696228	0.0209739866918654	0.0164168856697462	ILK/FNBP1/ACTN1/TRAF5/MYL9/VCL	6
MD117	hsa04022	cGMP-PKG signaling pathway	5/44	166/7846	0.00222472960961415	0.0216911136937379	0.0169781996523185	PDE3A/PPP1R12A/MYL9/MRVI1/MYLK	5
MD119	hsa05330	Allograft rejection	3/5	35/7846	8.08388632234059e-07	9.64426708753503e-06	9.22896372012921e-07	HLA-A/HLA-C/HLA-B	3
MD119	hsa05332	Graft-versus-host disease	3/5	37/7846	9.59323196757551e-07	9.64426708753503e-06	9.22896372012921e-07	HLA-A/HLA-C/HLA-B	3
MD119	hsa04940	Type I diabetes mellitus	3/5	41/7846	1.31512733011841e-06	9.64426708753503e-06	9.22896372012921e-07	HLA-A/HLA-C/HLA-B	3
MD119	hsa05320	Autoimmune thyroid disease	3/5	50/7846	2.41388315149309e-06	1.3276357333212e-05	1.27046481657531e-06	HLA-A/HLA-C/HLA-B	3
MD119	hsa05416	Viral myocarditis	3/5	57/7846	3.59873949888626e-06	1.58344537950995e-05	1.51525873637316e-06	HLA-A/HLA-C/HLA-B	3
MD119	hsa04612	Antigen processing and presentation	3/5	68/7846	6.1508325450165e-06	2.25530526650605e-05	2.15818685790053e-06	HLA-A/HLA-C/HLA-B	3
MD119	hsa04650	Natural killer cell mediated cytotoxicity	3/5	125/7846	3.85716803418225e-05	0.000121225281074299	1.16005053659617e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa04514	Cell adhesion molecules (CAMs)	3/5	144/7846	5.8941566270024e-05	0.000156390485076228	1.49655966580122e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa04145	Phagosome	3/5	148/7846	6.39779257130022e-05	0.000156390485076228	1.49655966580122e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa04218	Cellular senescence	3/5	160/7846	8.07722288743064e-05	0.000177698903523474	1.70046797630119e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/5	188/7846	0.00013068882847632	0.000261377656952639	2.50122159763291e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05169	Epstein-Barr virus infection	3/5	199/7846	0.000154803603684643	0.000273904814674328	2.62109870501749e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05203	Viral carcinogenesis	3/5	202/7846	0.00016185284503483	0.000273904814674328	2.62109870501749e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05170	Human immunodeficiency virus 1 infection	3/5	212/7846	0.000186867811877456	0.000293649418664574	2.81004228387152e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05166	Human T-cell leukemia virus 1 infection	3/5	218/7846	0.000203029377981672	0.000297776421039785	2.84953512956732e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05163	Human cytomegalovirus infection	3/5	224/7846	0.000220083001809096	0.000302614127487507	2.89582897117232e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa04144	Endocytosis	3/5	247/7846	0.000294122258267833	0.000380628804817196	3.64238090734159e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05165	Human papillomavirus infection	3/5	332/7846	0.000704635265051056	0.000861220879506847	8.24134812925212e-05	HLA-A/HLA-C/HLA-B	3
MD119	hsa05168	Herpes simplex virus 1 infection	3/5	489/7846	0.00218881986560245	0.00253442300227652	0.000242528516964261	HLA-A/HLA-C/HLA-B	3
MD123	hsa04660	T cell receptor signaling pathway	6/37	105/7846	8.26153154919063e-06	0.000661199330187359	0.000441126313690603	NFATC2/SOS1/NFKBIA/JUN/FOS/MAP3K8	6
MD123	hsa05161	Hepatitis B	7/37	164/7846	9.31266662235718e-06	0.000661199330187359	0.000441126313690603	NFATC2/SOS1/EGR3/NFKBIA/JUN/FOS/STAT4	7
MD123	hsa04380	Osteoclast differentiation	6/37	127/7846	2.46195801901842e-05	0.00116532679566872	0.00077746042705845	NFATC2/NFKBIA/JUN/FOSB/FOS/SQSTM1	6
MD123	hsa04662	B cell receptor signaling pathway	5/37	81/7846	3.48337836835093e-05	0.00123659932076458	0.000825010666188379	NFATC2/SOS1/NFKBIA/JUN/FOS	5
MD123	hsa04658	Th1 and Th2 cell differentiation	5/37	90/7846	5.79458280923696e-05	0.0016456615178233	0.00109792095332911	NFATC2/NFKBIA/JUN/FOS/STAT4	5
MD123	hsa04620	Toll-like receptor signaling pathway	5/37	104/7846	0.000115599132058094	0.00245388195940893	0.00163713399812308	CCL4L2/NFKBIA/JUN/FOS/MAP3K8	5
MD123	hsa04659	Th17 cell differentiation	5/37	105/7846	0.000120966012083539	0.00245388195940893	0.00163713399812308	NFATC2/NFKBIA/JUN/FOS/RORA	5
MD123	hsa04668	TNF signaling pathway	5/37	114/7846	0.000178350479941308	0.00316572101895821	0.0021120451571997	ICAM1/NFKBIA/JUN/FOS/MAP3K8	5
MD123	hsa05167	Kaposi sarcoma-associated herpesvirus infection	6/37	188/7846	0.000218795441194217	0.0034521058499532	0.00230310990730754	NFATC2/CLEC2B/ICAM1/NFKBIA/JUN/FOS	6
MD123	hsa05135	Yersinia infection	5/37	122/7846	0.000245057804216491	0.00347982081987418	0.00232160025047202	NFATC2/NFKBIA/JUN/FOS/WIPF1	5
MD123	hsa05418	Fluid shear stress and atherosclerosis	5/37	140/7846	0.00046360213994083	0.0057446695694972	0.0038326186898054	ICAM1/JUN/DUSP1/FOS/SQSTM1	5
MD123	hsa05166	Human T-cell leukemia virus 1 infection	6/37	218/7846	0.000485465034042017	0.0057446695694972	0.0038326186898054	NFATC2/ICAM1/EGR1/NFKBIA/JUN/FOS	6
MD123	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/37	91/7846	0.000834713013718668	0.00911763445754238	0.00608292884491337	NFATC2/NFKBIA/JUN/FOS	4
MD123	hsa04657	IL-17 signaling pathway	4/37	94/7846	0.000942851233676007	0.00956320537014236	0.00638019631810832	NFKBIA/JUN/FOSB/FOS	4
MD123	hsa04064	NF-kappa B signaling pathway	4/37	100/7846	0.00118818264179138	0.0112481290089584	0.0075043114218403	ICAM1/CCL4L2/NFKBIA/TNFSF14	4
MD123	hsa04625	C-type lectin receptor signaling pathway	4/37	106/7846	0.00147524999333652	0.0130928436908616	0.00873503285528201	NFATC2/EGR3/NFKBIA/JUN	4
MD123	hsa05130	Pathogenic Escherichia coli infection	5/37	200/7846	0.00229783621180252	0.0184011191374652	0.0122765064668041	TUBB4B/NFKBIA/JUN/FOS/WIPF1	5
MD123	hsa04010	MAPK signaling pathway	6/37	295/7846	0.00233253622869277	0.0184011191374652	0.0122765064668041	SOS1/JUN/DUSP1/FOS/DUSP5/MAP3K8	6
MD123	hsa05321	Inflammatory bowel disease (IBD)	3/37	63/7846	0.00315606975244095	0.0227165654922622	0.0151556033677064	JUN/STAT4/RORA	3
MD123	hsa04926	Relaxin signaling pathway	4/37	131/7846	0.0031995162665158	0.0227165654922622	0.0151556033677064	SOS1/NFKBIA/JUN/FOS	4
MD123	hsa05031	Amphetamine addiction	3/37	69/7846	0.00408410461325544	0.0276163264324892	0.0184245320898742	JUN/FOSB/FOS	3
MD123	hsa05140	Leishmaniasis	3/37	73/7846	0.00478594657772531	0.0308911097289543	0.0206093393299176	NFKBIA/JUN/FOS	3
MD123	hsa05132	Salmonella infection	3/37	78/7846	0.00576029752597482	0.0355635760299315	0.0237266259651137	CCL4L2/JUN/FOS	3
MD123	hsa05210	Colorectal cancer	3/37	88/7846	0.00804533989415972	0.0471395194465384	0.0314496423290471	SOS1/JUN/FOS	3
MD123	hsa05323	Rheumatoid arthritis	3/37	89/7846	0.00829921117016521	0.0471395194465384	0.0314496423290471	ICAM1/JUN/FOS	3
MD127	hsa04713	Circadian entrainment	3/7	97/7846	6.18559889873108e-05	0.00334022340531478	0.00201845858800698	KCNJ6/NOS1/CACNA1D	3
MD135	hsa04514	Cell adhesion molecules (CAMs)	10/27	144/7846	2.04794918877905e-11	1.80219528612557e-09	1.18565479350366e-09	HLA-F/HLA-C/HLA-A/HLA-B/CD40LG/CD28/ICOS/CD226/CD6/CD4	10
MD135	hsa05330	Allograft rejection	6/27	35/7846	1.3898433484816e-09	6.11531073331906e-08	4.02323074560464e-08	HLA-F/HLA-C/HLA-A/HLA-B/CD40LG/CD28	6
MD135	hsa05320	Autoimmune thyroid disease	6/27	50/7846	1.31443668726656e-08	3.85568094931523e-07	2.53663220349686e-07	HLA-F/HLA-C/HLA-A/HLA-B/CD40LG/CD28	6
MD135	hsa05416	Viral myocarditis	6/27	57/7846	2.95361710812623e-08	6.4979576378777e-07	4.2749721301827e-07	HLA-F/HLA-C/HLA-A/HLA-B/CD40LG/CD28	6
MD135	hsa05332	Graft-versus-host disease	5/27	37/7846	1.31934667824583e-07	2.32205015371265e-06	1.52766457481096e-06	HLA-F/HLA-C/HLA-A/HLA-B/CD28	5
MD135	hsa04940	Type I diabetes mellitus	5/27	41/7846	2.24706374198957e-07	3.29569348825137e-06	2.16821940016538e-06	HLA-F/HLA-C/HLA-A/HLA-B/CD28	5
MD135	hsa04612	Antigen processing and presentation	5/27	68/7846	2.93385178252316e-06	3.68827081231483e-05	2.42649395547028e-05	HLA-F/HLA-C/HLA-A/HLA-B/CD4	5
MD135	hsa05340	Primary immunodeficiency	4/27	35/7846	5.41498445266034e-06	5.95648289792637e-05	3.91873874863577e-05	CD40LG/IL7R/ICOS/CD4	4
MD135	hsa04660	T cell receptor signaling pathway	5/27	105/7846	2.49149535630234e-05	0.000243612879282895	0.000160271631107168	ITK/CD40LG/CD28/ICOS/CD4	5
MD135	hsa05167	Kaposi sarcoma-associated herpesvirus infection	6/27	188/7846	3.40013401490559e-05	0.000299211793311692	0.00019684986402085	HLA-F/HLA-C/HLA-A/HLA-B/STAT1/IL6ST	6
MD135	hsa05169	Epstein-Barr virus infection	6/27	199/7846	4.6828832045194e-05	0.000374630656361552	0.000246467537079968	CD44/HLA-F/HLA-C/HLA-A/HLA-B/STAT1	6
MD135	hsa04640	Hematopoietic cell lineage	4/27	95/7846	0.000285940613509456	0.00209689783240267	0.00137953804763334	CD44/IL7R/CD4/CD5	4
MD135	hsa04672	Intestinal immune network for IgA production	3/27	46/7846	0.000499930644479762	0.00338414590109378	0.00222641177703538	CD40LG/CD28/ICOS	3
MD135	hsa05203	Viral carcinogenesis	5/27	202/7846	0.000547516333461187	0.00344153123889889	0.00226416528874927	HLA-F/HLA-C/HLA-A/HLA-B/IL6ST	5
MD135	hsa05170	Human immunodeficiency virus 1 infection	5/27	212/7846	0.000682504816633549	0.00400402825758349	0.00263422911683124	HLA-F/HLA-C/HLA-A/HLA-B/CD4	5
MD135	hsa05166	Human T-cell leukemia virus 1 infection	5/27	218/7846	0.000774699738172194	0.00426084855994707	0.00280318984207044	HLA-F/HLA-C/HLA-A/HLA-B/CD4	5
MD135	hsa05168	Herpes simplex virus 1 infection	7/27	489/7846	0.00104016778287228	0.00538439793486826	0.00354236706241333	HLA-F/HLA-C/HLA-A/HLA-B/BIRC3/SOCS3/STAT1	7
MD135	hsa04145	Phagosome	4/27	148/7846	0.00152181514059455	0.0074399851317956	0.00489472706039184	HLA-F/HLA-C/HLA-A/HLA-B	4
MD135	hsa04218	Cellular senescence	4/27	160/7846	0.00202716826157309	0.00938898984307534	0.00617696700202325	HLA-F/HLA-C/HLA-A/HLA-B	4
MD135	hsa04630	JAK-STAT signaling pathway	4/27	164/7846	0.00221874014618027	0.00976245664319318	0.00642266884420604	IL7R/SOCS3/STAT1/IL6ST	4
MD135	hsa04060	Cytokine-cytokine receptor interaction	5/27	291/7846	0.00279572491477593	0.0117154186904896	0.00770751229637474	IL32/CD40LG/IL7R/CD4/IL6ST	5
MD135	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/27	91/7846	0.00360927648872307	0.0144371059548923	0.00949809602295545	CD28/CD4/STAT1	3
MD135	hsa04064	NF-kappa B signaling pathway	3/27	100/7846	0.00470624383346034	0.0180064981454135	0.0118463803588247	BCL2A1/CD40LG/BIRC3	3
MD135	hsa05165	Human papillomavirus infection	5/27	332/7846	0.004925606788659	0.018060558225083	0.0118819462007125	HLA-F/HLA-C/HLA-A/HLA-B/STAT1	5
MD135	hsa04659	Th17 cell differentiation	3/27	105/7846	0.00539401872394209	0.0189869459082762	0.0124914117817606	CD4/STAT1/IL6ST	3
MD135	hsa05145	Toxoplasmosis	3/27	110/7846	0.00613955076612418	0.0207800179776511	0.013671064458981	CD40LG/BIRC3/STAT1	3
MD135	hsa05163	Human cytomegalovirus infection	4/27	224/7846	0.00677358747875498	0.0220768777085347	0.0145242616503518	HLA-F/HLA-C/HLA-A/HLA-B	4
MD135	hsa04650	Natural killer cell mediated cytotoxicity	3/27	125/7846	0.00873501548845981	0.0274529058208737	0.0180611222505748	HLA-C/HLA-A/HLA-B	3
MD135	hsa04144	Endocytosis	4/27	247/7846	0.00951159303086988	0.0288627650591913	0.0189886612231522	HLA-F/HLA-C/HLA-A/HLA-B	4
MD137	hsa05016	Huntington disease	5/20	192/7846	9.57496065657069e-05	0.00564922678737671	0.00493866391759962	ATP5E/NDUFS5/COX7A2/UQCRC2/SOD2	5
MD137	hsa04714	Thermogenesis	5/20	230/7846	0.000224076748378917	0.00570992809325667	0.00499173017965347	ATP5E/NDUFS5/COX7A2/UQCRC2/COA1	5
MD137	hsa00190	Oxidative phosphorylation	4/20	132/7846	0.000300878312523442	0.00570992809325667	0.00499173017965347	ATP5E/NDUFS5/COX7A2/UQCRC2	4
MD137	hsa05012	Parkinson disease	4/20	141/7846	0.00038711376903435	0.00570992809325667	0.00499173017965347	ATP5E/NDUFS5/COX7A2/UQCRC2	4
MD137	hsa05010	Alzheimer disease	4/20	170/7846	0.000785734348941564	0.00927166531751046	0.0081054701259235	ATP5E/NDUFS5/COX7A2/UQCRC2	4
MD139	hsa03010	Ribosome	3/8	150/7846	0.000357486781138196	0.00250240746796737	0.00150520749952925	RPL22L1/RPL18/RPL23A	3
MD140	hsa03010	Ribosome	64/85	150/7846	5.82276184257283e-98	4.48352661878108e-96	4.48352661878108e-96	RPL41/RPL29/FAU/RPS10/RPS28/RPS29/RPL35/RPS19/RPL30/RPL35A/RPLP1/RPS7/RPL37/RPL24/RPL39/RPS25/RPL7A/RPL21/RPS11/RPL14/RPL38/RPS5/RPL32/RPL6/RPL26/RPL10/RPL27/RPS15A/RPL36/RPS21/RPLP2/RPL12/RPS2/RPL10A/RPS27A/RPS24/RPSA/RPLP0/RPL13/RPL27A/RPL13A/RPS16/RPL22/RPL19/RPL8/RPL9/RPL31/RPL37A/RPL3/RPS4X/RPL23/RPL5/RPL11/RPL4/RPL34/RPL7/RPS3/RPS23/RPS12/RPS18/RPS3A/RPS6/RPS17/RPS20	64
MD141	hsa00190	Oxidative phosphorylation	4/8	132/7846	5.08624628519904e-06	8.13799405631847e-05	4.2831547664834e-05	NDUFB5/COX6B1/ATP5L/ATP5O	4
MD141	hsa05016	Huntington disease	4/8	192/7846	2.25311134403082e-05	0.000180248907522465	9.48678460644555e-05	NDUFB5/COX6B1/RCOR1/ATP5O	4
MD141	hsa04714	Thermogenesis	4/8	230/7846	4.59087060733285e-05	0.000244846432391085	0.000128866543363729	NDUFB5/COX6B1/ATP5L/ATP5O	4
MD141	hsa05012	Parkinson disease	3/8	141/7846	0.000297831510403535	0.00119132604161414	0.000627013706112706	NDUFB5/COX6B1/ATP5O	3
MD141	hsa05010	Alzheimer disease	3/8	170/7846	0.000516613757316269	0.00165316402341206	0.000870086328111611	NDUFB5/COX6B1/ATP5O	3
MD142	hsa04141	Protein processing in endoplasmic reticulum	8/16	166/7846	3.78120364406228e-10	1.43685738474367e-08	7.96042872434164e-09	HSPA8/DNAJA1/HSP90AB1/DNAJB1/HSPH1/HSP90AA1/HSPA1A/HSPA1B	8
MD142	hsa04612	Antigen processing and presentation	5/16	68/7846	1.70897375466242e-07	2.43311541250249e-06	1.34798637811773e-06	HSPA8/HSP90AB1/HSP90AA1/HSPA1A/HSPA1B	5
MD142	hsa04915	Estrogen signaling pathway	6/16	139/7846	1.92088058881776e-07	2.43311541250249e-06	1.34798637811773e-06	FKBP4/HSPA8/HSP90AB1/HSP90AA1/HSPA1A/HSPA1B	6
MD142	hsa05134	Legionellosis	4/16	57/7846	4.26967212528965e-06	4.05618851902517e-05	2.24719585541561e-05	HSPA8/HSPD1/HSPA1A/HSPA1B	4
MD142	hsa04213	Longevity regulating pathway - multiple species	3/16	64/7846	0.000268750689812765	0.00204250524257701	0.00113158185184322	HSPA8/HSPA1A/HSPA1B	3
MD142	hsa04144	Endocytosis	4/16	247/7846	0.00129386303052822	0.00713641148261557	0.00395369057208619	UBB/HSPA8/HSPA1A/HSPA1B	4
MD142	hsa05145	Toxoplasmosis	3/16	110/7846	0.00131460211521866	0.00713641148261557	0.00395369057208619	HSPA8/HSPA1A/HSPA1B	3
MD142	hsa03040	Spliceosome	3/16	135/7846	0.00236760717190465	0.00997971247426326	0.0055289265785392	HSPA8/HSPA1A/HSPA1B	3
MD142	hsa04010	MAPK signaling pathway	4/16	295/7846	0.00249016287227795	0.00997971247426326	0.0055289265785392	NR4A1/HSPA8/HSPA1A/HSPA1B	4
MD142	hsa05162	Measles	3/16	140/7846	0.00262624012480612	0.00997971247426326	0.0055289265785392	HSPA8/HSPA1A/HSPA1B	3
MD143	hsa00100	Steroid biosynthesis	4/10	20/7846	6.38566538729842e-09	1.40484638520565e-07	1.07548048628184e-07	DHCR24/MSMO1/FDFT1/SQLE	4
MD143	hsa01100	Metabolic pathways	6/10	1488/7846	0.00480105510315531	0.0303362153384491	0.0232238969098175	HMGCS1/HMGCR/DHCR24/MSMO1/FDFT1/SQLE	6
MD145	hsa01524	Platinum drug resistance	4/19	74/7846	2.5389018808511e-05	0.00201767979107405	0.00167934180897228	PIK3CD/GSTM4/GSTM2/GSTM1	4
MD145	hsa00983	Drug metabolism - other enzymes	4/19	78/7846	3.12818572259542e-05	0.00201767979107405	0.00167934180897228	UPP1/GSTM4/GSTM2/GSTM1	4
MD145	hsa00480	Glutathione metabolism	3/19	55/7846	0.000291741939733812	0.00985586834823015	0.00820317071823317	GSTM4/GSTM2/GSTM1	3
MD145	hsa05418	Fluid shear stress and atherosclerosis	4/19	140/7846	0.000305608320875353	0.00985586834823015	0.00820317071823317	PIK3CD/GSTM4/GSTM2/GSTM1	4
MD145	hsa00982	Drug metabolism - cytochrome P450	3/19	69/7846	0.000570283265433456	0.0123994854848126	0.0103202571966616	GSTM4/GSTM2/GSTM1	3
MD145	hsa05225	Hepatocellular carcinoma	4/19	168/7846	0.000611374634845827	0.0123994854848126	0.0103202571966616	PIK3CD/GSTM4/GSTM2/GSTM1	4
MD145	hsa00980	Metabolism of xenobiotics by cytochrome P450	3/19	73/7846	0.000672840297625488	0.0123994854848126	0.0103202571966616	GSTM4/GSTM2/GSTM1	3
MD145	hsa04662	B cell receptor signaling pathway	3/19	81/7846	0.000911761978635	0.013068588360435	0.0108771604468737	PPP3CC/VAV3/PIK3CD	3
MD145	hsa05204	Chemical carcinogenesis	3/19	81/7846	0.000911761978635	0.013068588360435	0.0108771604468737	GSTM4/GSTM2/GSTM1	3
MD145	hsa04660	T cell receptor signaling pathway	3/19	105/7846	0.00193100760614284	0.0232693848152956	0.0193674194301114	PPP3CC/VAV3/PIK3CD	3
MD145	hsa04625	C-type lectin receptor signaling pathway	3/19	106/7846	0.00198421110828102	0.0232693848152956	0.0193674194301114	PPP3CC/KSR1/PIK3CD	3
MD145	hsa04670	Leukocyte transendothelial migration	3/19	114/7846	0.00244310919218857	0.0262634238160271	0.0218593980353714	VAV3/TXK/PIK3CD	3
MD145	hsa05135	Yersinia infection	3/19	122/7846	0.00296312874389385	0.0292501832042971	0.0243453177220588	VAV3/WIPF3/PIK3CD	3
MD145	hsa04650	Natural killer cell mediated cytotoxicity	3/19	125/7846	0.00317443848728806	0.0292501832042971	0.0243453177220588	PPP3CC/VAV3/PIK3CD	3
MD146	hsa04650	Natural killer cell mediated cytotoxicity	18/67	125/7846	6.08801554639497e-18	1.10193081389749e-15	7.94646239739975e-16	FYN/MAPK1/CD244/CD247/KIR2DL4/FCER1G/IFNG/FASLG/PLCG2/PRF1/GZMB/FCGR3A/SYK/SH2D1B/NCR1/KLRD1/KLRC2/KLRC1	18
MD146	hsa05332	Graft-versus-host disease	6/67	37/7846	5.83071061962292e-07	5.27679311075875e-05	3.8053058780697e-05	IFNG/FASLG/PRF1/GZMB/KLRD1/KLRC1	6
MD146	hsa04664	Fc epsilon RI signaling pathway	7/67	69/7846	1.70774630540655e-06	0.000103034027092862	7.43019445159341e-05	FYN/MAPK1/ALOX5AP/LYN/FCER1G/PLCG2/SYK	7
MD146	hsa05163	Human cytomegalovirus infection	10/67	224/7846	1.7541111122905e-05	0.000747279430045069	0.000538892988226744	JAK1/GNGT2/CCR1/TBK1/MAPK1/CCL5/CCL3L3/FASLG/CCL3/CCL4	10
MD146	hsa04612	Antigen processing and presentation	6/67	68/7846	2.23162635955742e-05	0.000747279430045069	0.000538892988226744	KLRC4/KIR2DL4/IFNG/KLRD1/KLRC2/KLRC1	6
MD146	hsa05142	Chagas disease (American trypanosomiasis)	7/67	103/7846	2.49564949580277e-05	0.000747279430045069	0.000538892988226744	MAPK1/CD247/CCL5/IFNG/CCL3L3/FASLG/CCL3	7
MD146	hsa04062	Chemokine signaling pathway	9/67	189/7846	2.89003094492568e-05	0.000747279430045069	0.000538892988226744	GNGT2/CCR1/MAPK1/CCL5/LYN/CCL3L3/CCL3/CCL4/FGR	9
MD146	hsa04611	Platelet activation	7/67	125/7846	8.66399666338467e-05	0.00192648877451111	0.00138926785716416	FYN/ITGB1/MAPK1/LYN/FCER1G/PLCG2/SYK	7
MD146	hsa04380	Osteoclast differentiation	7/67	127/7846	9.57922595060772e-05	0.00192648877451111	0.00138926785716416	FYN/JAK1/MAPK1/IFNG/PLCG2/FCGR3A/SYK	7
MD146	hsa04061	Viral protein interaction with cytokine and cytokine receptor	6/67	98/7846	0.000175684714234314	0.00290134802209089	0.00209227772456685	CCR1/CCL5/CCL3L3/CCL3/CCL4/IL2RB	6
MD146	hsa05167	Kaposi sarcoma-associated herpesvirus infection	8/67	188/7846	0.000182209894623293	0.00290134802209089	0.00209227772456685	JAK1/GNGT2/CCR1/TBK1/MAPK1/LYN/PLCG2/SYK	8
MD146	hsa05020	Prion diseases	4/67	35/7846	0.000208384112083876	0.00290134802209089	0.00209227772456685	FYN/MAPK1/CCL5/NCAM1	4
MD146	hsa05330	Allograft rejection	4/67	35/7846	0.000208384112083876	0.00290134802209089	0.00209227772456685	IFNG/FASLG/PRF1/GZMB	4
MD146	hsa04620	Toll-like receptor signaling pathway	6/67	104/7846	0.000243325392171658	0.00314584971307644	0.00226859764129967	TBK1/MAPK1/CCL5/CCL3L3/CCL3/CCL4	6
MD146	hsa05140	Leishmaniasis	5/67	73/7846	0.000374439904004256	0.00438732848020424	0.00316387747336624	JAK1/ITGB1/MAPK1/IFNG/FCGR3A	5
MD146	hsa04940	Type I diabetes mellitus	4/67	41/7846	0.000387830141896507	0.00438732848020424	0.00316387747336624	IFNG/FASLG/PRF1/GZMB	4
MD146	hsa05132	Salmonella infection	5/67	78/7846	0.000509272836929093	0.00542225785200975	0.00391020630211811	MAPK1/IFNG/CCL3L3/CCL3/CCL4	5
MD146	hsa04662	B cell receptor signaling pathway	5/67	81/7846	0.000606027153072329	0.00609393970589398	0.00439458286438414	PIK3AP1/MAPK1/LYN/PLCG2/SYK	5
MD146	hsa04151	PI3K-Akt signaling pathway	10/67	355/7846	0.000783362457199	0.00746255814489574	0.00538154818241973	AREG/PDGFD/JAK1/GNGT2/ITGB1/PIK3AP1/MAPK1/FASLG/SYK/IL2RB	10
MD146	hsa04658	Th1 and Th2 cell differentiation	5/67	90/7846	0.000979924203559136	0.00886831404221018	0.00639529480217541	JAK1/MAPK1/CD247/IFNG/IL2RB	5
MD146	hsa04666	Fc gamma R-mediated phagocytosis	5/67	93/7846	0.00113621787447542	0.00979311596571675	0.00706220633759161	MAPK1/LYN/PLCG2/FCGR3A/SYK	5
MD146	hsa04072	Phospholipase D signaling pathway	6/67	149/7846	0.00163124941428927	0.0134207338175617	0.00967822619004158	FYN/PDGFD/MAPK1/FCER1G/PLCG2/SYK	6
MD146	hsa04659	Th17 cell differentiation	5/67	105/7846	0.00195144799931144	0.0145765513090148	0.0105117322612262	JAK1/MAPK1/CD247/IFNG/IL2RB	5
MD146	hsa04660	T cell receptor signaling pathway	5/67	105/7846	0.00195144799931144	0.0145765513090148	0.0105117322612262	CBLB/FYN/MAPK1/CD247/IFNG	5
MD146	hsa04625	C-type lectin receptor signaling pathway	5/67	106/7846	0.00203469123872305	0.0145765513090148	0.0105117322612262	CBLB/MAPK1/FCER1G/PLCG2/SYK	5
MD146	hsa05170	Human immunodeficiency virus 1 infection	7/67	212/7846	0.00209386924880876	0.0145765513090148	0.0105117322612262	GNGT2/TBK1/MAPK1/CD247/APOBEC3G/FASLG/PLCG2	7
MD146	hsa04060	Cytokine-cytokine receptor interaction	8/67	291/7846	0.00316620274387746	0.0204911452803202	0.0147769817665583	CCR1/CCL5/IFNG/CCL3L3/FASLG/CCL3/CCL4/IL2RB	8
MD146	hsa05164	Influenza A	6/67	170/7846	0.00316990092734235	0.0204911452803202	0.0147769817665583	JAK1/TBK1/MAPK1/CCL5/IFNG/FASLG	6
MD146	hsa04014	Ras signaling pathway	7/67	234/7846	0.00364102371033842	0.0227001398383359	0.0163699758066511	PDGFD/GNGT2/TBK1/MAPK1/PLA2G16/FASLG/PLCG2	7
MD146	hsa05152	Tuberculosis	6/67	176/7846	0.00376245411685125	0.0227001398383359	0.0163699758066511	JAK1/MAPK1/FCER1G/IFNG/FCGR3A/SYK	6
MD146	hsa05200	Pathways in cancer	11/67	531/7846	0.00493487468053195	0.0279189231639125	0.0201334485159939	DAPK2/JAK1/NCOA1/GNGT2/ITGB1/MAPK1/GSTP1/IFNG/FASLG/PLCG2/IL2RB	11
MD146	hsa01521	EGFR tyrosine kinase inhibitor resistance	4/67	81/7846	0.0049359422168243	0.0279189231639125	0.0201334485159939	PDGFD/JAK1/MAPK1/PLCG2	4
MD146	hsa04210	Apoptosis	5/67	138/7846	0.0063142107572302	0.0332593546844466	0.0239846465883768	MAPK1/CTSW/FASLG/PRF1/GZMB	5
MD146	hsa04012	ErbB signaling pathway	4/67	87/7846	0.00635673729221233	0.0332593546844466	0.0239846465883768	CBLB/AREG/MAPK1/PLCG2	4
MD146	hsa05162	Measles	5/67	140/7846	0.00670442041204988	0.0332593546844466	0.0239846465883768	CBLB/JAK1/TBK1/FASLG/IL2RB	5
MD146	hsa05169	Epstein-Barr virus infection	6/67	199/7846	0.00681814986100061	0.0332593546844466	0.0239846465883768	JAK1/TBK1/CD247/LYN/PLCG2/SYK	6
MD146	hsa05323	Rheumatoid arthritis	4/67	89/7846	0.00688485845616038	0.0332593546844466	0.0239846465883768	CCL5/IFNG/CCL3L3/CCL3	4
MD146	hsa05130	Pathogenic Escherichia coli infection	6/67	200/7846	0.00698262695032581	0.0332593546844466	0.0239846465883768	FYN/MYO5B/ITGB1/MAPK1/LYN/FASLG	6
MD146	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/67	91/7846	0.00744131746639554	0.0345353451645537	0.0249048141925249	JAK1/MAPK1/CD247/IFNG	4
MD146	hsa05205	Proteoglycans in cancer	6/67	206/7846	0.00803077793069159	0.0363392701363795	0.0262056964054147	IQGAP1/ITGB1/MAPK1/FASLG/PLCG2/CD63	6
MD146	hsa05320	Autoimmune thyroid disease	3/67	50/7846	0.00876249945570725	0.0386832293044637	0.0278960188063594	FASLG/PRF1/GZMB	3
MD146	hsa04810	Regulation of actin cytoskeleton	6/67	215/7846	0.00981008463305212	0.0422767932995817	0.0304874810651244	SSH1/PDGFD/IQGAP1/ITGB1/MAPK1/ITGAE	6
MD146	hsa04064	NF-kappa B signaling pathway	4/67	100/7846	0.0103122695090255	0.0434074600263633	0.0313028499172379	LYN/CCL4/PLCG2/SYK	4
MD146	hsa05160	Hepatitis C	5/67	157/7846	0.010729557753734	0.0441374989414968	0.0318293100828474	JAK1/TBK1/MAPK1/IFNG/FASLG	5
MD147	hsa04810	Regulation of actin cytoskeleton	11/27	215/7846	4.4999354270078e-11	3.86994446722671e-09	2.69996125620468e-09	RAC2/MYL12A/ARPC3/TMSB4X/RHOA/PFN1/ARPC2/ACTB/ACTG1/MSN/ARPC5	11
MD147	hsa05131	Shigellosis	9/27	236/7846	5.05806389740955e-08	1.76308712417631e-06	1.23006078430905e-06	UBE2D2/MYL12A/ARPC3/RHOA/PFN1/ARPC2/ACTB/ACTG1/ARPC5	9
MD147	hsa04530	Tight junction	8/27	169/7846	6.15030392154526e-08	1.76308712417631e-06	1.23006078430905e-06	MYL12A/MYL6/ACTR2/RHOA/ACTR3/ACTB/ACTG1/MSN	8
MD147	hsa05100	Bacterial invasion of epithelial cells	6/27	75/7846	1.57226054649868e-07	3.38036017497216e-06	2.35839081974802e-06	ARPC3/RHOA/ARPC2/ACTB/ACTG1/ARPC5	6
MD147	hsa05132	Salmonella infection	6/27	78/7846	1.99171237040973e-07	3.42574527710473e-06	2.39005484449167e-06	ARPC3/PFN1/ARPC2/ACTB/ACTG1/ARPC5	6
MD147	hsa04670	Leukocyte transendothelial migration	6/27	114/7846	1.90290443328952e-06	2.72749635438165e-05	1.90290443328952e-05	RAC2/MYL12A/RHOA/ACTB/ACTG1/MSN	6
MD147	hsa05135	Yersinia infection	6/27	122/7846	2.83121777962578e-06	3.47835327211168e-05	2.4267580968221e-05	RAC2/ACTR2/RHOA/ACTR3/ACTB/ACTG1	6
MD147	hsa05130	Pathogenic Escherichia coli infection	6/27	200/7846	4.81649987201742e-05	0.000517773736241872	0.000361237490401306	ARPC3/RHOA/ARPC2/ACTB/ACTG1/ARPC5	6
MD147	hsa04520	Adherens junction	4/27	71/7846	9.23341732252515e-05	0.000882304321930181	0.00061556115483501	RAC2/RHOA/ACTB/ACTG1	4
MD147	hsa04666	Fc gamma R-mediated phagocytosis	4/27	93/7846	0.000263481134962707	0.00226593776067928	0.00158088680977624	RAC2/ARPC3/ARPC2/ARPC5	4
MD147	hsa04510	Focal adhesion	5/27	201/7846	0.000535224576187497	0.00418448305019315	0.00291940677920453	RAC2/MYL12A/RHOA/ACTB/ACTG1	5
MD147	hsa04015	Rap1 signaling pathway	5/27	212/7846	0.000682504816633549	0.0048912845192071	0.00341252408316774	RAC2/RHOA/PFN1/ACTB/ACTG1	5
MD147	hsa04611	Platelet activation	4/27	125/7846	0.00081120708847358	0.00536644689297907	0.00374403271603191	MYL12A/RHOA/ACTB/ACTG1	4
MD147	hsa05416	Viral myocarditis	3/27	57/7846	0.000939646659136111	0.00577211519183611	0.00402705711058333	RAC2/ACTB/ACTG1	3
MD147	hsa05418	Fluid shear stress and atherosclerosis	4/27	140/7846	0.00123870773588622	0.00710192435241434	0.00495483094354489	RAC2/RHOA/ACTB/ACTG1	4
MD147	hsa04144	Endocytosis	5/27	247/7846	0.00135824338864574	0.00730055821397085	0.00509341270742152	ARPC3/CAPZB/RHOA/ARPC2/ARPC5	5
MD147	hsa04921	Oxytocin signaling pathway	4/27	153/7846	0.00172013534165545	0.00870186114013935	0.00607106591172513	MYL6/RHOA/ACTB/ACTG1	4
MD147	hsa05410	Hypertrophic cardiomyopathy (HCM)	3/27	90/7846	0.00349827798574782	0.0167139948207951	0.0116609266191594	ACTB/ACTG1/TPM3	3
MD147	hsa05414	Dilated cardiomyopathy (DCM)	3/27	95/7846	0.00407483237869602	0.0184439781351504	0.012867891722198	ACTB/ACTG1/TPM3	3
MD147	hsa05205	Proteoglycans in cancer	4/27	206/7846	0.00504229862614976	0.0216818840924439	0.0151268958784493	RHOA/ACTB/ACTG1/MSN	4
MD147	hsa04714	Thermogenesis	4/27	230/7846	0.00742891207188053	0.0304231637229393	0.0212254630625158	UQCR10/NDUFA1/ACTB/ACTG1	4
MD152	hsa04714	Thermogenesis	3/8	230/7846	0.00124849000688197	0.0399516802202229	0.0381118002100811	KDM1A/NDUFAF2/NDUFB10	3
MD153	hsa01200	Carbon metabolism	3/16	117/7846	0.00157074106921296	0.0295300791806174	0.0250401256209913	DLAT/IDH3B/GCSH	3
MD153	hsa03013	RNA transport	3/16	164/7846	0.00411020402167256	0.0445423827975752	0.0377698567581778	RAE1/EIF2B3/EIF5B	3
MD153	hsa01100	Metabolic pathways	8/16	1488/7846	0.00494915364417502	0.0445423827975752	0.0377698567581778	UCKL1/AKR1A1/DDOST/DLAT/IDH3B/GCDH/ALDH18A1/GCSH	8
MD154	hsa03050	Proteasome	3/14	45/7846	6.14110920464463e-05	0.00184233276139339	0.00122822184092893	PSMD7/PSMB6/PSMB7	3
MD154	hsa05016	Huntington disease	4/14	192/7846	0.000287009574549643	0.00430514361824464	0.00287009574549643	NDUFA12/GPX1/ATP5C1/COX5A	4
MD154	hsa00190	Oxidative phosphorylation	3/14	132/7846	0.00147922378149582	0.013413391978757	0.00894226131917135	NDUFA12/ATP5C1/COX5A	3
MD154	hsa05012	Parkinson disease	3/14	141/7846	0.00178845226383427	0.013413391978757	0.00894226131917135	NDUFA12/ATP5C1/COX5A	3
MD154	hsa05010	Alzheimer disease	3/14	170/7846	0.00305102687435596	0.0183061612461358	0.0122041074974239	NDUFA12/ATP5C1/COX5A	3
MD154	hsa04714	Thermogenesis	3/14	230/7846	0.00712394881070712	0.0356197440535356	0.0237464960356904	NDUFA12/ATP5C1/COX5A	3
MD158	hsa01100	Metabolic pathways	6/10	1488/7846	0.00480105510315531	0.0274826090940752	0.0182145947212194	PI4K2B/PMM1/PFKP/AHCYL1/GBE1/BCAT1	6
MD159	hsa05012	Parkinson disease	11/44	141/7846	1.97074506547598e-10	1.08390978601179e-08	8.50532080889633e-09	VDAC1/ATP5J/NDUFB6/ATP5G3/SLC25A5/ATP5A1/ATP5B/COX6C/UQCRH/NDUFS6/PARK7	11
MD159	hsa05016	Huntington disease	10/44	192/7846	7.3355529781396e-08	2.01727706898839e-06	1.58293511633539e-06	VDAC1/ATP5J/NDUFB6/ATP5G3/SLC25A5/ATP5A1/ATP5B/COX6C/UQCRH/NDUFS6	10
MD159	hsa03050	Proteasome	6/44	45/7846	1.51136252339581e-07	2.77083129289233e-06	2.17424082313082e-06	PSME2/PSME1/PSMA4/SEM1/PSMB4/PSMA7	6
MD159	hsa00190	Oxidative phosphorylation	8/44	132/7846	5.52621721560185e-07	7.59854867145255e-06	5.96249752209674e-06	ATP5J/NDUFB6/ATP5G3/ATP5A1/ATP5B/COX6C/UQCRH/NDUFS6	8
MD159	hsa05010	Alzheimer disease	8/44	170/7846	3.75527640650647e-06	4.13080404715711e-05	3.24139647719506e-05	ATP5J/NDUFB6/ATP5G3/ATP5A1/ATP5B/COX6C/UQCRH/NDUFS6	8
MD159	hsa04714	Thermogenesis	8/44	230/7846	3.43723221439996e-05	0.000315079619653329	0.000247239510158593	ATP5J/NDUFB6/ATP5G3/ATP5A1/ATP5B/COX6C/UQCRH/NDUFS6	8
MD159	hsa03013	RNA transport	5/44	164/7846	0.00210972637666029	0.0158487161776231	0.0124363131728717	MAGOH/KPNB1/EIF3B/RAN/SEH1L	5
MD159	hsa03040	Spliceosome	4/44	135/7846	0.00668101839457149	0.0367456011701432	0.0288338688607822	PPIH/MAGOH/SNRPF/SNRPD1	4
MD159	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	4/44	150/7846	0.00962707564189929	0.0481353782094964	0.0377713015615187	NDUFB6/COX6C/UQCRH/NDUFS6	4
MD162	hsa04110	Cell cycle	4/16	124/7846	9.33765725506235e-05	0.00532246463538554	0.00452139193403019	BUB3/SMC3/PTTG1/RB1	4
MD165	hsa01200	Carbon metabolism	5/19	117/7846	6.65960713128235e-06	0.000279703499513859	0.000224323608632669	FH/TPI1/PKM/GAPDH/SHMT1	5
MD165	hsa01230	Biosynthesis of amino acids	4/19	75/7846	2.67782280212851e-05	0.000562342788446986	0.000451001735095327	TPI1/PKM/GAPDH/SHMT1	4
MD165	hsa00010	Glycolysis / Gluconeogenesis	3/19	68/7846	0.000546324105466791	0.00764853747653507	0.00613416539471484	TPI1/PKM/GAPDH	3
MD165	hsa03040	Spliceosome	3/19	135/7846	0.00394524635322305	0.031900848863742	0.0255846406927254	SRSF1/LSM3/SF3A3	3
MD165	hsa01100	Metabolic pathways	9/19	1488/7846	0.00455726412339172	0.031900848863742	0.0255846406927254	FH/SMS/TPI1/PKM/GAPDH/DCTPP1/GGCT/SHMT1/GMPS	9
MD166	hsa03030	DNA replication	19/99	36/7846	9.74333284800854e-28	1.18868660745704e-25	1.05638240352093e-25	PRIM1/POLE/RFC2/LIG1/RFC4/DNA2/RFC3/PCNA/RFC5/RNASEH2A/MCM6/POLA1/MCM5/MCM3/MCM7/MCM2/MCM4/FEN1/POLD3	19
MD166	hsa04110	Cell cycle	27/99	124/7846	6.71312050216468e-27	4.09500350632046e-25	3.63921795643664e-25	PRKDC/CDK4/CCNE1/YWHAQ/SMC1A/MAD2L2/CHEK2/CDC7/WEE1/BUB1/ORC6/CCNB1/ESPL1/CDK1/MAD2L1/CDC45/CDC25A/CDC6/CDK2/PCNA/MCM6/MCM5/MCM3/MCM7/CHEK1/MCM2/MCM4	27
MD166	hsa03460	Fanconi anemia pathway	11/99	54/7846	4.4790789487395e-11	1.82149210582073e-09	1.61875484814094e-09	RMI1/BLM/USP1/RMI2/BRIP1/FANCG/FANCD2/BRCA2/FANCI/RAD51/BRCA1	11
MD166	hsa03440	Homologous recombination	9/99	41/7846	1.4070725499005e-09	4.29157127719652e-08	3.8139071747303e-08	BARD1/BLM/TOPBP1/BRIP1/BRCA2/RAD51/RAD54L/BRCA1/POLD3	9
MD166	hsa03410	Base excision repair	8/99	32/7846	3.95577990865661e-09	9.65210297712212e-08	8.57779643350801e-08	UNG/POLE/HMGB1/LIG1/PARP2/PCNA/FEN1/POLD3	8
MD166	hsa03430	Mismatch repair	7/99	23/7846	8.54298997117095e-09	1.73707462747143e-07	1.54373327549229e-07	RFC2/LIG1/RFC4/RFC3/PCNA/RFC5/POLD3	7
MD166	hsa04114	Oocyte meiosis	12/99	125/7846	4.49543004886116e-08	7.83489237087231e-07	6.96284654184511e-07	CCNE1/YWHAQ/SMC1A/MAD2L2/CALM3/FBXO5/BUB1/CCNB1/ESPL1/CDK1/MAD2L1/CDK2	12
MD166	hsa03420	Nucleotide excision repair	8/99	46/7846	8.48750747391477e-08	1.294344889772e-06	1.15028061817529e-06	POLE/RFC2/LIG1/RFC4/RFC3/PCNA/RFC5/POLD3	8
MD166	hsa04115	p53 signaling pathway	9/99	72/7846	2.47690661554402e-07	3.357584523293e-06	2.98387580586004e-06	CDK4/CCNE1/CHEK2/CCNB1/GTSE1/RRM2/CDK1/CDK2/CHEK1	9
MD166	hsa04218	Cellular senescence	11/99	160/7846	4.82508913675956e-06	5.88660874684666e-05	5.23141243248668e-05	CDK4/CCNE1/LIN54/CHEK2/CALM3/CCNB1/FOXM1/CDK1/CDC25A/CDK2/CHEK1	11
MD166	hsa04914	Progesterone-mediated oocyte maturation	8/99	98/7846	2.9872188257915e-05	0.000331309724315057	0.00029443400866653	MAD2L2/BUB1/KIF22/CCNB1/CDK1/MAD2L1/CDC25A/CDK2	8
MD166	hsa00240	Pyrimidine metabolism	5/99	57/7846	0.000719814123478703	0.00731811025536682	0.00650358374721986	CTPS1/RRM1/RRM2/DUT/TYMS	5
MD166	hsa00670	One carbon pool by folate	3/99	20/7846	0.00190088330119871	0.0178390586727879	0.0158535206496734	MTHFD1/DHFR/TYMS	3
MD167	hsa00190	Oxidative phosphorylation	9/16	132/7846	8.50031103747167e-13	3.26710915917717e-11	2.53835548708001e-11	MT-ND1/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ND4/MT-ND5/MT-ATP6/MT-CO1	9
MD167	hsa05012	Parkinson disease	9/16	141/7846	1.55576626627484e-12	3.26710915917717e-11	2.53835548708001e-11	MT-ND1/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ND4/MT-ND5/MT-ATP6/MT-CO1	9
MD167	hsa04714	Thermogenesis	9/16	230/7846	1.30975310925821e-10	1.83365435296149e-09	1.42464373287735e-09	MT-ND1/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ND4/MT-ND5/MT-ATP6/MT-CO1	9
MD167	hsa05010	Alzheimer disease	5/16	170/7846	1.62076790242128e-05	0.000170180629754235	0.000132220539408052	MT-CO2/MT-CO3/MT-CYB/MT-ATP6/MT-CO1	5
MD167	hsa04260	Cardiac muscle contraction	4/16	85/7846	2.11453977018299e-05	0.000177621340695371	0.000138001542896153	MT-CO2/MT-CO3/MT-CYB/MT-CO1	4
MD167	hsa05016	Huntington disease	5/16	192/7846	2.92169264688078e-05	0.000204518485281655	0.000158899073777727	MT-CO2/MT-CO3/MT-CYB/MT-ATP6/MT-CO1	5
MD167	hsa01100	Metabolic pathways	10/16	1488/7846	0.000152936430548397	0.00091137888242162	0.000708088856016797	EARS2/MT-ND1/MT-CO2/MT-CO3/MT-ND2/MT-CYB/MT-ND4/MT-ND5/MT-ATP6/MT-CO1	10
MD167	hsa04723	Retrograde endocannabinoid signaling	4/16	147/7846	0.000180652758547991	0.00091137888242162	0.000708088856016797	MT-ND1/MT-ND2/MT-ND4/MT-ND5	4
MD167	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	4/16	150/7846	0.000195295474804633	0.00091137888242162	0.000708088856016797	MT-CO2/MT-CO3/MT-CYB/MT-CO1	4
MD170	hsa03010	Ribosome	7/9	150/7846	2.83068735044335e-11	1.41534367522168e-10	1.19186835808141e-10	RPS3A/RPL6/RPS16/RPL5/RPL4/RPL3/RPL9	7
MD171	hsa03010	Ribosome	5/6	150/7846	1.41230343833885e-08	2.8246068766777e-08	1.48663519825142e-08	RPS25/RPL38/RPL10A/RPS18/RPL7	5
MD172	hsa03010	Ribosome	25/27	150/7846	4.61729259151254e-42	6.0024803689663e-41	5.83236958927899e-41	RPL30/RPL26/RPL27/RPS27A/RPL32/RPL36/RPL8/RPS23/RPS24/RPLP1/RPL14/RPL27A/RPL13A/RPLP2/RPL22/RPL11/RPS12/RPS6/RPS3/RPL34/RPS17/RPL37A/RPL31/RPS20/RPL23	25
MD173	hsa04974	Protein digestion and absorption	7/23	95/7846	6.38699094185498e-09	2.87414592383474e-07	2.21863895874963e-07	COL6A3/COL12A1/COL4A1/COL5A2/COL1A1/COL3A1/COL1A2	7
MD173	hsa04512	ECM-receptor interaction	5/23	88/7846	4.54262575824454e-06	0.000102209079560502	7.8898236853721e-05	COL6A3/LAMC1/COL4A1/COL1A1/COL1A2	5
MD173	hsa05146	Amoebiasis	5/23	102/7846	9.4014128250374e-06	0.000141021192375561	0.000108858464289907	LAMC1/COL4A1/COL1A1/COL3A1/COL1A2	5
MD173	hsa04933	AGE-RAGE signaling pathway in diabetic complications	4/23	102/7846	0.000197158284606499	0.00203897332698819	0.00157394432258737	COL4A1/COL1A1/COL3A1/COL1A2	4
MD173	hsa04510	Focal adhesion	5/23	201/7846	0.000242472599103292	0.00203897332698819	0.00157394432258737	COL6A3/LAMC1/COL4A1/COL1A1/COL1A2	5
MD173	hsa05205	Proteoglycans in cancer	5/23	206/7846	0.000271863110265092	0.00203897332698819	0.00157394432258737	PLAU/COL1A1/COL1A2/LUM/DCN	5
MD173	hsa04611	Platelet activation	4/23	125/7846	0.000429960032822629	0.00276402878243119	0.00213363625310478	PTGS1/COL1A1/COL3A1/COL1A2	4
MD173	hsa04926	Relaxin signaling pathway	4/23	131/7846	0.000513779216718417	0.0028900080940411	0.00223088344101418	COL4A1/COL1A1/COL3A1/COL1A2	4
MD173	hsa05165	Human papillomavirus infection	5/23	332/7846	0.00235846142903799	0.01179230714519	0.00910283358576067	COL6A3/LAMC1/COL4A1/COL1A1/COL1A2	5
MD173	hsa04151	PI3K-Akt signaling pathway	5/23	355/7846	0.0031585723873165	0.0142135757429243	0.0109718830296257	COL6A3/LAMC1/COL4A1/COL1A1/COL1A2	5
MD177	hsa04974	Protein digestion and absorption	4/18	95/7846	5.41978259038084e-05	0.00300816877449419	0.00216125743196743	COL15A1/SLC7A7/COL4A6/COL4A5	4
MD177	hsa04510	Focal adhesion	5/18	201/7846	6.85363227760945e-05	0.00300816877449419	0.00216125743196743	PIK3CA/VEGFA/COL4A6/COL4A5/PDGFRA	5
MD177	hsa04933	AGE-RAGE signaling pathway in diabetic complications	4/18	102/7846	7.16230660593856e-05	0.00300816877449419	0.00216125743196743	PIK3CA/VEGFA/COL4A6/COL4A5	4
MD177	hsa04926	Relaxin signaling pathway	4/18	131/7846	0.000189417089907375	0.0059666383320823	0.00428680782421953	PIK3CA/VEGFA/COL4A6/COL4A5	4
MD177	hsa04370	VEGF signaling pathway	3/18	61/7846	0.000335801004126764	0.00846218530399444	0.00607976554840035	PIK3CA/PPP3CA/VEGFA	3
MD177	hsa04218	Cellular senescence	4/18	160/7846	0.000407722731457808	0.00856217736061397	0.00615160612374939	PIK3CA/ZFP36L2/PPP3CA/HIPK2	4
MD177	hsa01521	EGFR tyrosine kinase inhibitor resistance	3/18	81/7846	0.000773534057705454	0.0135269243081222	0.00971859223474112	PIK3CA/VEGFA/PDGFRA	3
MD177	hsa05200	Pathways in cancer	6/18	531/7846	0.000858852337023634	0.0135269243081222	0.00971859223474112	PIK3CA/VEGFA/COL4A6/COL4A5/PDGFRA/DLL1	6
MD177	hsa04151	PI3K-Akt signaling pathway	5/18	355/7846	0.000969119334945339	0.0135676706892347	0.00974786699477183	PIK3CA/VEGFA/COL4A6/COL4A5/PDGFRA	5
MD177	hsa05222	Small cell lung cancer	3/18	94/7846	0.00119280438826048	0.0146396442397089	0.0105180401388051	PIK3CA/COL4A6/COL4A5	3
MD177	hsa05215	Prostate cancer	3/18	99/7846	0.00138575226482356	0.0146396442397089	0.0105180401388051	PIK3CA/PLAT/PDGFRA	3
MD177	hsa05163	Human cytomegalovirus infection	4/18	224/7846	0.00144390008158845	0.0146396442397089	0.0105180401388051	PIK3CA/PPP3CA/VEGFA/PDGFRA	4
MD177	hsa05146	Amoebiasis	3/18	102/7846	0.00151043948504933	0.0146396442397089	0.0105180401388051	PIK3CA/COL4A6/COL4A5	3
MD177	hsa05418	Fluid shear stress and atherosclerosis	3/18	140/7846	0.00372826696868609	0.0335544027181748	0.0241075909253386	PIK3CA/VEGFA/PLAT	3
MD177	hsa05206	MicroRNAs in cancer	4/18	312/7846	0.00482212402682049	0.0405058418252921	0.0291019414951973	PIK3CA/SPRY2/VEGFA/PDGFRA	4
MD177	hsa05165	Human papillomavirus infection	4/18	332/7846	0.00601312757777678	0.0473533796749921	0.0340216428742633	PIK3CA/VEGFA/COL4A6/COL4A5	4
MD178	hsa05200	Pathways in cancer	6/12	531/7846	6.07164677938463e-05	0.00242865871175385	0.00166171385541053	MMP1/HHIP/PTCH1/LAMA4/CXCR4/LAMB1	6
MD178	hsa04024	cAMP signaling pathway	4/12	217/7846	0.000236595684558823	0.00473191369117646	0.00323762515712074	ATP2B4/HHIP/PTCH1/SOX9	4
MD180	hsa04141	Protein processing in endoplasmic reticulum	10/38	166/7846	3.88769349472529e-09	4.89849380335386e-07	3.11015479578023e-07	HSPH1/HSP90AB1/HSPA8/ATF4/HSPA1A/HSPA1B/PPP1R15A/DNAJA1/DNAJB1/HSP90AA1	10
MD180	hsa04915	Estrogen signaling pathway	8/38	139/7846	2.47703883382488e-07	1.10715257470846e-05	7.02954015687913e-06	HSP90AB1/HSPA8/ATF4/HSPA1A/HSPA1B/HSP90AA1/JUN/FOS	8
MD180	hsa04657	IL-17 signaling pathway	7/38	94/7846	2.63607755882967e-07	1.10715257470846e-05	7.02954015687913e-06	HSP90AB1/JUND/NFKBIA/HSP90AA1/JUN/FOS/FOSB	7
MD180	hsa04010	MAPK signaling pathway	10/38	295/7846	8.99559418247296e-07	2.49057516143986e-05	1.58131756281896e-05	HSPA8/ATF4/HSPA1A/HSPA1B/GADD45B/DUSP5/JUND/DUSP1/JUN/FOS	10
MD180	hsa04668	TNF signaling pathway	7/38	114/7846	9.88323476761847e-07	2.49057516143986e-05	1.58131756281896e-05	ATF4/NFKBIA/JUNB/IRF1/SOCS3/JUN/FOS	7
MD180	hsa04380	Osteoclast differentiation	7/38	127/7846	2.05113662058743e-06	4.3073869032336e-05	2.7348488274499e-05	JUND/NFKBIA/JUNB/SOCS3/JUN/FOS/FOSB	7
MD180	hsa04612	Antigen processing and presentation	5/38	68/7846	1.69449141438681e-05	0.000305008454589625	0.000193656161644206	HSP90AB1/HSPA8/HSPA1A/HSPA1B/HSP90AA1	5
MD180	hsa04210	Apoptosis	6/38	138/7846	4.6132458084173e-05	0.000630239705086947	0.000400152193705998	ATF4/GADD45B/NFKBIA/MCL1/JUN/FOS	6
MD180	hsa05162	Measles	6/38	140/7846	5.00190242132498e-05	0.000630239705086947	0.000400152193705998	HSPA8/HSPA1A/HSPA1B/NFKBIA/JUN/FOS	6
MD180	hsa05418	Fluid shear stress and atherosclerosis	6/38	140/7846	5.00190242132498e-05	0.000630239705086947	0.000400152193705998	HSP90AB1/KLF2/HSP90AA1/DUSP1/JUN/FOS	6
MD180	hsa05166	Human T-cell leukemia virus 1 infection	7/38	218/7846	7.03320153518389e-05	0.000805621266757427	0.000511505566195192	EGR2/ATF4/NFKBIA/ZFP36/JUN/EGR1/FOS	7
MD180	hsa05161	Hepatitis B	6/38	164/7846	0.00012069875058996	0.00126733688119458	0.000804658337266402	EGR2/DDX3X/ATF4/NFKBIA/JUN/FOS	6
MD180	hsa04659	Th17 cell differentiation	5/38	105/7846	0.00013782377217464	0.00133583040723113	0.000848146290305476	HSP90AB1/NFKBIA/HSP90AA1/JUN/FOS	5
MD180	hsa05134	Legionellosis	4/38	57/7846	0.000153749702239166	0.0013837473201525	0.000878569727080951	HSPA8/HSPA1A/HSPA1B/NFKBIA	4
MD180	hsa05031	Amphetamine addiction	4/38	69/7846	0.000322782811563882	0.00271137561713661	0.0017215083283407	ATF4/JUN/FOS/FOSB	4
MD180	hsa03040	Spliceosome	5/38	135/7846	0.00044533847812145	0.00350704051520642	0.00222669239060725	HSPA8/SRSF7/HSPA1A/HSPA1B/DDX5	5
MD180	hsa05215	Prostate cancer	4/38	99/7846	0.0012668728630079	0.00938976357288208	0.00596175464944894	HSP90AB1/ATF4/NFKBIA/HSP90AA1	4
MD180	hsa04625	C-type lectin receptor signaling pathway	4/38	106/7846	0.00163185125637618	0.0104339249579512	0.00662471425901662	EGR2/NFKBIA/IRF1/JUN	4
MD180	hsa04928	Parathyroid hormone synthesis, secretion and action	4/38	106/7846	0.00163185125637618	0.0104339249579512	0.00662471425901662	ATF4/JUND/EGR1/FOS	4
MD180	hsa05030	Cocaine addiction	3/38	49/7846	0.00165617856475416	0.0104339249579512	0.00662471425901662	ATF4/JUN/FOSB	3
MD180	hsa05145	Toxoplasmosis	4/38	110/7846	0.00187040413036699	0.011222424782202	0.00712534906806474	HSPA8/HSPA1A/HSPA1B/NFKBIA	4
MD180	hsa04935	Growth hormone synthesis, secretion and action	4/38	121/7846	0.00264968780473702	0.0148275919788196	0.00941434411353625	ATF4/JUNB/SOCS3/FOS	4
MD180	hsa05203	Viral carcinogenesis	5/38	202/7846	0.00270662393264167	0.0148275919788196	0.00941434411353625	EGR2/DDX3X/ATF4/NFKBIA/JUN	5
MD180	hsa04926	Relaxin signaling pathway	4/38	131/7846	0.00353032009890649	0.0179566057521249	0.0114010195251587	ATF4/NFKBIA/JUN/FOS	4
MD180	hsa04213	Longevity regulating pathway - multiple species	3/38	64/7846	0.00356281860161209	0.0179566057521249	0.0114010195251587	HSPA8/HSPA1A/HSPA1B	3
MD180	hsa04917	Prolactin signaling pathway	3/38	72/7846	0.0049661580944769	0.0240667661501573	0.0152804864445443	IRF1/SOCS3/FOS	3
MD180	hsa05140	Leishmaniasis	3/38	73/7846	0.00516181631266433	0.0240884761257669	0.0152942705560425	NFKBIA/JUN/FOS	3
MD180	hsa05133	Pertussis	3/38	76/7846	0.00577654551583459	0.0259944548212557	0.0165044157595274	IRF1/JUN/FOS	3
MD180	hsa04662	B cell receptor signaling pathway	3/38	81/7846	0.00689534208510161	0.0299590725076828	0.0190216333382113	NFKBIA/JUN/FOS	3
MD180	hsa05210	Colorectal cancer	3/38	88/7846	0.00866506390819317	0.0363932684144113	0.0231068370885151	GADD45B/JUN/FOS	3
MD180	hsa04658	Th1 and Th2 cell differentiation	3/38	90/7846	0.00921526455840445	0.0373979696144446	0.0237447426123458	NFKBIA/JUN/FOS	3
MD180	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/38	91/7846	0.00949789704493831	0.0373979696144446	0.0237447426123458	NFKBIA/JUN/FOS	3
MD180	hsa04912	GnRH signaling pathway	3/38	93/7846	0.0100783216031425	0.0384808643029076	0.0244322947954969	ATF4/JUN/EGR1	3
MD180	hsa04621	NOD-like receptor signaling pathway	4/38	180/7846	0.0107636697919391	0.0398888939348332	0.0253262818633862	HSP90AB1/NFKBIA/HSP90AA1/JUN	4
MD180	hsa05167	Kaposi sarcoma-associated herpesvirus infection	4/38	188/7846	0.0124787819417058	0.0436757367959702	0.0277306265371239	NFKBIA/ZFP36/JUN/FOS	4
MD180	hsa05142	Chagas disease (American trypanosomiasis)	3/38	103/7846	0.0132880151686208	0.0452058660213671	0.0287021371564235	NFKBIA/JUN/FOS	3
MD180	hsa04620	Toll-like receptor signaling pathway	3/38	104/7846	0.0136375324156762	0.0452058660213671	0.0287021371564235	NFKBIA/JUN/FOS	3
MD180	hsa04660	T cell receptor signaling pathway	3/38	105/7846	0.0139922918637565	0.0452058660213671	0.0287021371564235	NFKBIA/JUN/FOS	3
MD180	hsa05130	Pathogenic Escherichia coli infection	4/38	200/7846	0.0153668702208779	0.0484056411957653	0.0307337404417557	NFKBIA/TUBB4B/JUN/FOS	4
MD181	hsa04540	Gap junction	3/11	88/7846	0.000210811425249036	0.00948651413620663	0.00776673671970134	TUBB/TUBA1B/TUBA1A	3
MD181	hsa04145	Phagosome	3/11	148/7846	0.000971111295149999	0.0213947439394355	0.0175161646287776	TUBB/TUBA1B/TUBA1A	3
MD181	hsa04530	Tight junction	3/11	169/7846	0.00142631626262903	0.0213947439394355	0.0175161646287776	TUBA1B/TUBA1A/MYL6	3
MD181	hsa05130	Pathogenic Escherichia coli infection	3/11	200/7846	0.00231449109185657	0.0260380247833864	0.0213176811092053	TUBB/TUBA1B/TUBA1A	3
MD185	hsa03040	Spliceosome	3/11	135/7846	0.000742981371715581	0.0237754038948986	0.0211163126698113	DDX39B/U2AF1L5/U2AF1	3
MD189	hsa04974	Protein digestion and absorption	6/24	95/7846	3.0339202510665e-07	1.91136975817189e-05	1.62873613478307e-05	COL14A1/COL5A1/COL5A2/COL3A1/COL1A2/COL1A1	6
MD189	hsa05205	Proteoglycans in cancer	7/24	206/7846	1.83930589744429e-06	5.79381357694951e-05	4.93708425103467e-05	IGF2/LUM/DCN/GPC3/CD63/COL1A2/COL1A1	7
MD189	hsa04926	Relaxin signaling pathway	4/24	131/7846	0.000608616735629597	0.0127809514482215	0.0108910363217928	CREB5/COL3A1/COL1A2/COL1A1	4
MD189	hsa04512	ECM-receptor interaction	3/24	88/7846	0.0023272124659705	0.0345981375942298	0.0294821222607472	THBS2/COL1A2/COL1A1	3
MD189	hsa04933	AGE-RAGE signaling pathway in diabetic complications	3/24	102/7846	0.0035405982845574	0.0345981375942298	0.0294821222607472	COL3A1/COL1A2/COL1A1	3
MD189	hsa05146	Amoebiasis	3/24	102/7846	0.0035405982845574	0.0345981375942298	0.0294821222607472	COL3A1/COL1A2/COL1A1	3
MD189	hsa04151	PI3K-Akt signaling pathway	5/24	355/7846	0.00384423751046998	0.0345981375942298	0.0294821222607472	IGF2/CREB5/THBS2/COL1A2/COL1A1	5
MD189	hsa04611	Platelet activation	3/24	125/7846	0.00625744655814308	0.0492773916453768	0.0419907597980654	COL3A1/COL1A2/COL1A1	3
MD191	hsa04510	Focal adhesion	3/10	201/7846	0.00174012027432126	0.0220415234747359	0.0189276240364768	THBS3/PDGFD/VEGFD	3
MD193	hsa04210	Apoptosis	4/19	138/7846	0.000289222679887499	0.0312360494278499	0.0277044882839604	TUBA1B/TUBA1C/NFKBIA/GADD45A	4
MD193	hsa04918	Thyroid hormone synthesis	3/19	74/7846	0.000700197393913528	0.0378106592713305	0.0335357699190163	ATP1A1/HSPA5/HSP90B1	3
MD194	hsa04141	Protein processing in endoplasmic reticulum	12/75	166/7846	4.44977474757953e-08	8.00959454564316e-06	6.0891654440562e-06	HSPA1A/HSPA1B/HSP90AB1/DDIT3/PPP1R15A/ATF4/HERPUD1/HSPH1/HSP90AA1/HSPA8/DNAJB1/DNAJA1	12
MD194	hsa03040	Spliceosome	9/75	135/7846	4.85953426899814e-06	0.000370751411942069	0.00028185779855245	HSPA1A/HSPA1B/SRSF5/SRSF3/SRSF7/EIF4A3/DDX5/HSPA8/TRA2B	9
MD194	hsa04915	Estrogen signaling pathway	9/75	139/7846	6.17919019903449e-06	0.000370751411942069	0.00028185779855245	HSPA1A/HSPA1B/HSP90AB1/CALM1/ATF4/HSP90AA1/HSPA8/JUN/FOS	9
MD194	hsa04010	MAPK signaling pathway	12/75	295/7846	1.99338668346264e-05	0.000848310125089131	0.00064491413018472	JUND/HSPA1A/HSPA1B/MYC/DDIT3/DUSP5/GADD45B/DUSP1/ATF4/HSPA8/JUN/FOS	12
MD194	hsa05161	Hepatitis B	9/75	164/7846	2.35641701413648e-05	0.000848310125089131	0.00064491413018472	EGR2/CYCS/MYC/EGR3/CDKN1A/DDX3X/ATF4/JUN/FOS	9
MD194	hsa04612	Antigen processing and presentation	6/75	68/7846	4.26491213663982e-05	0.00105195664654596	0.000799733123105119	HSPA1A/HSPA1B/HSP90AB1/HSP90AA1/HSPA8/HLA-E	6
MD194	hsa05031	Amphetamine addiction	6/75	69/7846	4.63597943021651e-05	0.00105195664654596	0.000799733123105119	SIRT1/CALM1/ATF4/JUN/FOS/FOSB	6
MD194	hsa04210	Apoptosis	8/75	138/7846	4.67536287353762e-05	0.00105195664654596	0.000799733123105119	CYCS/DDIT3/GADD45B/TUBA1A/ATF4/JUN/FOS/MCL1	8
MD194	hsa05202	Transcriptional misregulation in cancer	9/75	184/7846	5.83894234540979e-05	0.00116778846908196	0.000887792403395641	FUS/MYC/H3F3B/CDKN1A/DDIT3/ID2/GADD45B/DDX5/NFKBIZ	9
MD194	hsa05210	Colorectal cancer	6/75	88/7846	0.000181603983956274	0.00320548174428514	0.00243691594594777	CYCS/MYC/CDKN1A/GADD45B/JUN/FOS	6
MD194	hsa05134	Legionellosis	5/75	57/7846	0.000198280283991799	0.00320548174428514	0.00243691594594777	HSPA1A/HSPA1B/CYCS/HSPA8/HSPD1	5
MD194	hsa05166	Human T-cell leukemia virus 1 infection	9/75	218/7846	0.000213698782952343	0.00320548174428514	0.00243691594594777	EGR2/MYC/CDKN1A/ATF4/JUN/FOS/EGR1/ZFP36/HLA-E	9
MD194	hsa04657	IL-17 signaling pathway	6/75	94/7846	0.000260789156948019	0.00361092678851103	0.00274514902050546	JUND/HSP90AB1/HSP90AA1/JUN/FOS/FOSB	6
MD194	hsa05167	Kaposi sarcoma-associated herpesvirus infection	8/75	188/7846	0.000400372587861816	0.00514764755822335	0.00391341627233354	CYCS/MYC/CDKN1A/CALM1/JUN/FOS/ZFP36/HLA-E	8
MD194	hsa05203	Viral carcinogenesis	8/75	202/7846	0.000645969330770961	0.00775163196925153	0.00589305354387544	GTF2B/EGR2/EGR3/CDKN1A/DDX3X/ATF4/JUN/HLA-E	8
MD194	hsa04668	TNF signaling pathway	6/75	114/7846	0.000734829981069874	0.00826683728703608	0.0062847301012555	JUNB/ATF4/JUN/FOS/SOCS3/IRF1	6
MD194	hsa04380	Osteoclast differentiation	6/75	127/7846	0.00129175053851842	0.0136773586431362	0.0103979919509223	JUNB/JUND/JUN/FOS/FOSB/SOCS3	6
MD194	hsa05222	Small cell lung cancer	5/75	94/7846	0.00197647160897974	0.0191371798947838	0.0145487332533444	CYCS/CKS2/MYC/CDKN1A/GADD45B	5
MD194	hsa05162	Measles	6/75	140/7846	0.00212635332164264	0.0191371798947838	0.0145487332533444	HSPA1A/HSPA1B/CYCS/HSPA8/JUN/FOS	6
MD194	hsa05418	Fluid shear stress and atherosclerosis	6/75	140/7846	0.00212635332164264	0.0191371798947838	0.0145487332533444	HSP90AB1/CALM1/DUSP1/HSP90AA1/JUN/FOS	6
MD194	hsa04213	Longevity regulating pathway - multiple species	4/75	64/7846	0.00317301865630337	0.0261376535577297	0.0198707307748822	HSPA1A/HSPA1B/SIRT1/HSPA8	4
MD194	hsa04625	C-type lectin receptor signaling pathway	5/75	106/7846	0.00333981128793213	0.0261376535577297	0.0198707307748822	EGR2/EGR3/CALM1/JUN/IRF1	5
MD194	hsa04928	Parathyroid hormone synthesis, secretion and action	5/75	106/7846	0.00333981128793213	0.0261376535577297	0.0198707307748822	JUND/CDKN1A/ATF4/FOS/EGR1	5
MD194	hsa04218	Cellular senescence	6/75	160/7846	0.00413465394024297	0.0310099045518223	0.0235747812382275	MYC/CDKN1A/SIRT1/GADD45B/CALM1/HLA-E	6
MD194	hsa05216	Thyroid cancer	3/75	37/7846	0.00516257243766758	0.0371705215512066	0.0282582912377594	MYC/CDKN1A/GADD45B	3
MD194	hsa05133	Pertussis	4/75	76/7846	0.00587921707464344	0.0407022720552238	0.0309432477612813	CALM1/JUN/FOS/IRF1	4
MD194	hsa03018	RNA degradation	4/75	79/7846	0.0067390425412178	0.0449269502747853	0.0341549914369713	TOB1/BTG2/BTG1/HSPD1	4
MD197	hsa03010	Ribosome	6/10	150/7846	8.71324528340441e-09	6.97059622672353e-08	6.42028599829799e-08	RPL39/RPL13/RPL24/RPL41/RPS19/RPL23A	6
MD198	hsa03010	Ribosome	41/50	150/7846	2.02983151798794e-64	1.03521407417385e-62	1.03521407417385e-62	RPLP0/RPL12/RPL14/RPL8/RPL36/RPLP1/RPL19/RPL32/RPL30/RPLP2/RPS11/RPS15A/RPL26/RPL27/RPL38/RPS23/RPL27A/RPL13A/RPS16/RPL7/RPS4X/RPL11/RPL22/RPS3/RPL31/RPS27A/RPS20/RPL23/RPL37A/RPS12/RPS24/RPS3A/RPL10A/RPS18/RPL15/RPS6/RPL4/RPL5/RPL9/RPL6/RPL3	41
MD203	hsa04510	Focal adhesion	5/23	201/7846	0.000242472599103292	0.0100589350798084	0.00872823669798452	CAV1/TNC/FN1/MYLK/IGF1	5
MD203	hsa05205	Proteoglycans in cancer	5/23	206/7846	0.000271863110265092	0.0100589350798084	0.00872823669798452	PTCH1/CAV1/WNT2B/FN1/IGF1	5
MD203	hsa04270	Vascular smooth muscle contraction	4/23	132/7846	0.000528805016913697	0.0130438570838712	0.0113182828181528	MRVI1/MYLK/CALD1/ACTA2	4
MD203	hsa05410	Hypertrophic cardiomyopathy (HCM)	3/23	90/7846	0.00218933575315763	0.0378135540189761	0.0328111919652567	TPM1/IGF1/TPM2	3
MD203	hsa05414	Dilated cardiomyopathy (DCM)	3/23	95/7846	0.00255496986614703	0.0378135540189761	0.0328111919652567	TPM1/IGF1/TPM2	3
MD205	hsa04510	Focal adhesion	7/23	201/7846	1.12909105238095e-06	5.12940455682825e-05	3.92681688561014e-05	COL6A3/MET/COL6A5/LAMA2/FN1/TNC/IGF1	7
MD205	hsa05205	Proteoglycans in cancer	7/23	206/7846	1.33231287190344e-06	5.12940455682825e-05	3.92681688561014e-05	GPC3/MET/FN1/WNT2B/IGF1/LUM/DCN	7
MD205	hsa04512	ECM-receptor interaction	5/23	88/7846	4.54262575824454e-06	0.000116594061128277	8.92586113900682e-05	COL6A3/COL6A5/LAMA2/FN1/TNC	5
MD205	hsa04151	PI3K-Akt signaling pathway	7/23	355/7846	4.7827819074143e-05	0.000920685517177253	0.000704831017934739	COL6A3/MET/COL6A5/LAMA2/FN1/TNC/IGF1	7
MD205	hsa05165	Human papillomavirus infection	6/23	332/7846	0.000300392376920667	0.00462604260457828	0.00354146802264366	COL6A3/COL6A5/LAMA2/FN1/TNC/WNT2B	6
MD205	hsa04360	Axon guidance	4/23	183/7846	0.00179176361097364	0.0229942996741617	0.0176032916165831	MET/ROBO2/SLIT3/NRP1	4
MD205	hsa04974	Protein digestion and absorption	3/23	95/7846	0.00255496986614703	0.0281046685276174	0.0215155357149224	COL6A3/COL6A5/COL21A1	3
MD208	hsa03010	Ribosome	10/23	150/7846	4.46481043700667e-12	1.91986848791287e-10	1.83292217940274e-10	RPL10A/RPL7/RPS3A/RPS18/RPS6/RPL5/RPL3/RPL9/RPL6/RPL4	10
MD208	hsa03013	RNA transport	4/23	164/7846	0.00119465986096704	0.0256851870107913	0.0245219655672182	EIF4B/PABPC1/EIF3E/EEF1A1	4
MD210	hsa00190	Oxidative phosphorylation	8/13	132/7846	6.22108043440905e-12	7.97894848861826e-11	2.23970483891039e-11	MT-ND1/MT-CO3/MT-ND2/MT-ATP6/MT-CYB/MT-ND5/MT-ND4/MT-CO1	8
MD210	hsa05012	Parkinson disease	8/13	141/7846	1.06385979848243e-11	7.97894848861826e-11	2.23970483891039e-11	MT-ND1/MT-CO3/MT-ND2/MT-ATP6/MT-CYB/MT-ND5/MT-ND4/MT-CO1	8
MD210	hsa04714	Thermogenesis	8/13	230/7846	5.48231327341555e-10	2.74115663670777e-09	7.69447476970603e-10	MT-ND1/MT-CO3/MT-ND2/MT-ATP6/MT-CYB/MT-ND5/MT-ND4/MT-CO1	8
MD210	hsa04723	Retrograde endocannabinoid signaling	4/13	147/7846	7.41524191469606e-05	0.000278071571801102	7.80551780494322e-05	MT-ND1/MT-ND2/MT-ND5/MT-ND4	4
MD210	hsa01100	Metabolic pathways	9/13	1488/7846	0.00010593933490431	0.00031781800471293	8.92120714983662e-05	SETD2/MT-ND1/MT-CO3/MT-ND2/MT-ATP6/MT-CYB/MT-ND5/MT-ND4/MT-CO1	9
MD210	hsa05010	Alzheimer disease	4/13	170/7846	0.000130561563481315	0.000326403908703288	9.16221498114494e-05	MT-CO3/MT-ATP6/MT-CYB/MT-CO1	4
MD210	hsa05016	Huntington disease	4/13	192/7846	0.00020898886075831	0.000447833273053522	0.000125707585418532	MT-CO3/MT-ATP6/MT-CYB/MT-CO1	4
MD210	hsa04260	Cardiac muscle contraction	3/13	85/7846	0.000324519439110631	0.000608473948332433	0.000170799704795069	MT-CO3/MT-CYB/MT-CO1	3
MD210	hsa04932	Non-alcoholic fatty liver disease (NAFLD)	3/13	150/7846	0.00170170040666134	0.00283616734443557	0.000796117149315246	MT-CO3/MT-CYB/MT-CO1	3
MD212	hsa04350	TGF-beta signaling pathway	3/15	94/7846	0.00068266030862774	0.0320850345055038	0.0229948735537765	BMP5/BMP4/LTBP1	3
MD212	hsa05418	Fluid shear stress and atherosclerosis	3/15	140/7846	0.00216187052482549	0.0333347800277235	0.0238905478362184	BMP4/VEGFA/MMP2	3
MD212	hsa04390	Hippo signaling pathway	3/15	154/7846	0.00283700255555094	0.0333347800277235	0.0238905478362184	BMP5/BMP4/WNT4	3
MD214	hsa05200	Pathways in cancer	7/15	531/7846	2.49382799436055e-05	0.00119703743729307	0.000866277092777876	CXCR4/PTCH1/F2R/DLL1/COL4A6/COL4A5/LAMB1	7
MD214	hsa04610	Complement and coagulation cascades	3/15	85/7846	0.000508252285214156	0.00819192370353288	0.00592836583808301	F2R/A2M/PLAT	3
MD214	hsa04512	ECM-receptor interaction	3/15	88/7846	0.000562735750990955	0.00819192370353288	0.00592836583808301	COL4A6/COL4A5/LAMB1	3
MD214	hsa05222	Small cell lung cancer	3/15	94/7846	0.00068266030862774	0.00819192370353288	0.00592836583808301	COL4A6/COL4A5/LAMB1	3
MD214	hsa05146	Amoebiasis	3/15	102/7846	0.000866422016469489	0.00831765135810709	0.00601935295652487	COL4A6/COL4A5/LAMB1	3
MD214	hsa04151	PI3K-Akt signaling pathway	4/15	355/7846	0.00378039502774136	0.0302431602219309	0.0218864975290289	F2R/COL4A6/COL4A5/LAMB1	4
MD214	hsa04510	Focal adhesion	3/15	201/7846	0.00600284102879796	0.041162338483186	0.0297885344286215	COL4A6/COL4A5/LAMB1	3
MD217	hsa04625	C-type lectin receptor signaling pathway	4/10	106/7846	6.20998348390198e-06	0.000310499174195099	0.000274546638235667	NFATC1/NFKB2/IRF9/IRF1	4
MD217	hsa04380	Osteoclast differentiation	3/10	127/7846	0.000457404034427579	0.00912034661660242	0.00806430648204845	NFATC1/NFKB2/IRF9	3
MD217	hsa03040	Spliceosome	3/10	135/7846	0.000547220796996145	0.00912034661660242	0.00806430648204845	U2AF1L5/U2AF1/DDX39B	3
MD221	hsa03010	Ribosome	23/27	150/7846	8.55232144681465e-37	7.69708930213318e-36	7.20195490258076e-36	RPL36/RPS21/RPL27A/RPL8/RPLP0/RPL14/RPS23/RPL26/RPL38/RPS11/RPS27A/RPL27/RPLP2/RPS4X/RPL13A/RPL22/RPL11/RPS24/RPS12/RPS3/RPS20/RPL31/RPL23	23
MD222	hsa04974	Protein digestion and absorption	5/19	95/7846	2.38017288393561e-06	0.000104727606893167	6.7647018806591e-05	COL5A2/COL1A1/COL3A1/COL1A2/COL9A1	5
MD222	hsa04611	Platelet activation	5/19	125/7846	9.21070429210024e-06	0.000202635494426205	0.000130888955729846	COL1A1/COL3A1/COL1A2/GUCY1A3/GUCY1B3	5
MD222	hsa04924	Renin secretion	3/19	68/7846	0.000546324105466791	0.00801275354684626	0.00517570205179065	GUCY1A3/GUCY1B3/EDNRA	3
MD222	hsa04512	ECM-receptor interaction	3/19	88/7846	0.00116018139958138	0.0127619953953952	0.00824339415492033	COL1A1/COL1A2/COL9A1	3
MD222	hsa04933	AGE-RAGE signaling pathway in diabetic complications	3/19	102/7846	0.00177680570492606	0.0130299085027911	0.00841644807596554	COL1A1/COL3A1/COL1A2	3
MD222	hsa05146	Amoebiasis	3/19	102/7846	0.00177680570492606	0.0130299085027911	0.00841644807596554	COL1A1/COL3A1/COL1A2	3
MD222	hsa04926	Relaxin signaling pathway	3/19	131/7846	0.00362448812978232	0.0203670899821536	0.013155775825793	COL1A1/COL3A1/COL1A2	3
MD222	hsa04270	Vascular smooth muscle contraction	3/19	132/7846	0.00370310726948248	0.0203670899821536	0.013155775825793	GUCY1A3/GUCY1B3/EDNRA	3
MD222	hsa04022	cGMP-PKG signaling pathway	3/19	166/7846	0.00702458564680979	0.0324139553632754	0.0209372438949387	GUCY1A3/GUCY1B3/EDNRA	3
MD222	hsa05165	Human papillomavirus infection	4/19	332/7846	0.00736680803710805	0.0324139553632754	0.0209372438949387	COL1A1/COL1A2/COL9A1/HEYL	4
MD222	hsa04151	PI3K-Akt signaling pathway	4/19	355/7846	0.00930396548110514	0.0341145400973855	0.0220357077184069	SGK1/COL1A1/COL1A2/COL9A1	4
MD222	hsa04510	Focal adhesion	3/19	201/7846	0.0118581184604338	0.040135170173776	0.0259246314519606	COL1A1/COL1A2/COL9A1	3
MD225	hsa04141	Protein processing in endoplasmic reticulum	7/10	166/7846	1.90354577981385e-10	5.32992818347878e-09	2.00373239980405e-09	HSPA8/HSP90AA1/HSPA1A/HSPA1B/DNAJB1/HSP90AB1/HSPH1	7
MD225	hsa04612	Antigen processing and presentation	5/10	68/7846	1.02647395999396e-08	1.43706354399155e-07	5.40249452628401e-08	HSPA8/HSP90AA1/HSPA1A/HSPA1B/HSP90AB1	5
MD225	hsa04915	Estrogen signaling pathway	5/10	139/7846	3.81128867432525e-07	3.55720276270356e-06	1.33729427169307e-06	HSPA8/HSP90AA1/HSPA1A/HSPA1B/HSP90AB1	5
MD225	hsa05134	Legionellosis	4/10	57/7846	5.08926201839275e-07	3.56248341287493e-06	1.33927947852441e-06	HSPA8/HSPA1A/HSPA1B/HSPD1	4
MD225	hsa04213	Longevity regulating pathway - multiple species	3/10	64/7846	5.96409943429203e-05	0.000333989568320354	0.000125559988090358	HSPA8/HSPA1A/HSPA1B	3
MD225	hsa05145	Toxoplasmosis	3/10	110/7846	0.000299526143390968	0.00139778866915785	0.000525484462089417	HSPA8/HSPA1A/HSPA1B	3
MD225	hsa03040	Spliceosome	3/10	135/7846	0.000547220796996145	0.0021305770426682	0.000800968813033158	HSPA8/HSPA1A/HSPA1B	3
MD225	hsa05162	Measles	3/10	140/7846	0.0006087362979052	0.0021305770426682	0.000800968813033158	HSPA8/HSPA1A/HSPA1B	3
MD225	hsa04144	Endocytosis	3/10	247/7846	0.00313873537888284	0.00976495451207994	0.00367103553085712	HSPA8/HSPA1A/HSPA1B	3
MD225	hsa04010	MAPK signaling pathway	3/10	295/7846	0.00518590936708595	0.0143014944097025	0.00537650165778288	HSPA8/HSPA1A/HSPA1B	3
MD226	hsa05160	Hepatitis C	7/38	157/7846	8.42032943656127e-06	0.000801985926109086	0.000554925852442061	CASP3/YWHAZ/EIF2AK3/CYCS/SOCS3/CDKN1A/MYC	7
MD226	hsa05161	Hepatitis B	7/38	164/7846	1.12165863791481e-05	0.000801985926109086	0.000554925852442061	CASP3/YWHAZ/CYCS/EGR3/CDKN1A/MYC/EGR2	7
MD226	hsa05210	Colorectal cancer	4/38	88/7846	0.000815226397102957	0.0335810286816904	0.0232360448736025	CASP3/CYCS/CDKN1A/MYC	4
MD226	hsa05222	Small cell lung cancer	4/38	94/7846	0.00104419422906854	0.0335810286816904	0.0232360448736025	CASP3/CYCS/CDKN1A/MYC	4
MD226	hsa04925	Aldosterone synthesis and secretion	4/38	97/7846	0.00117416184201715	0.0335810286816904	0.0232360448736025	ATP1A1/ATP1B3/NR4A1/NR4A2	4
MD226	hsa05167	Kaposi sarcoma-associated herpesvirus infection	5/38	188/7846	0.00197782513790831	0.0460112346051356	0.031836997076796	CASP3/CYCS/CDKN1A/MYC/ZFP36	5
MD226	hsa04919	Thyroid hormone signaling pathway	4/38	121/7846	0.00264968780473702	0.0460112346051356	0.031836997076796	ATP1A1/ATP2A2/ATP1B3/MYC	4
MD226	hsa05203	Viral carcinogenesis	5/38	202/7846	0.00270662393264167	0.0460112346051356	0.031836997076796	CASP3/YWHAZ/EGR3/CDKN1A/EGR2	5
MD226	hsa04110	Cell cycle	4/38	124/7846	0.00289581196815538	0.0460112346051356	0.031836997076796	YWHAZ/SKP1/CDKN1A/MYC	4
